Candidiasis

AB1_CANDIDIASIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B37 Hospital discharge: ICD-9 — 112 Hospital discharge: ICD-8 — 112 Cause of death: ICD-10 — B37 Cause of death: ICD-9 — 112 Cause of death: ICD-8 — 112 2 out of 7 registries used, show all original rules.	6025
4. Check minimum number of events None	6025
5. Include endpoints None	6025
6. Filter based on genotype QC (FinnGen only)	5784

Control definitions (FinnGen only)

Control exclude: AB1_MYCOSES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_CANDIDIASIS
CONTROL_EXCLUDE	AB1_MYCOSES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B37
HD_ICD_9	112
HD_ICD_8	112
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B37
COD_ICD_9	112
COD_ICD_8	112
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Candidiasis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Explicit fungal Sepsis

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	38361	25371	12707
Only index persons	33606	22803	10803
Unadjusted period prevalence (%)
Whole population	0.60	0.73	0.36
Only index persons	0.70	0.84	0.41
Median age at first event (years)
Whole population	43.09	37.41	54.38
Only index persons	41.76	36.25	53.38

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5784	3976	1808
Unadjusted period prevalence (%)	1.23	1.41	0.83
Median age at first event (years)	48.95	42.78	62.52

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6025: Matched controls
60245

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

5.8

307.7

907

1784

B37.03

ICD-10 Finland

Chronic atrophic candida infection in the mouth

144.1

307.7

262

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

48.0

307.7

617

143

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

102.8

307.7

256

B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

30.2

307.7

839

321

11299

ICD-8 Finland

Moniliasis

+∞

307.7

534

A07AA02

ATC

nystatin; oral

7.5

307.7

1032

1620

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.9

307.7

2417

11280

B37.4

ICD-10 Finland

Candidiasis of other urogenital sites

270.2

307.7

332

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

30.1

307.7

1097

442

B37.2

ICD-10 Finland

Candidiasis of skin and nail

28.7

307.7

319

117

B37.8

ICD-10 Finland

Candidiasis of other sites

138.1

307.7

226

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

3748.5

307.7

689

B37.08

ICD-10 Finland

Other candidal stomatitis

75.5

307.7

624

SBA00

NOMESCO Finland

Microbiological examinations

9.1

307.7

490

582

J02AC01

ATC

fluconazole; systemic

3.9

307.7

3819

18533

B37.01

ICD-10 Finland

Acute athrophy candidal stomatitis

69.9

276.1

150

B37.7

ICD-10 Finland

Candidal sepsis

2412.7

251.6

242

B37.0

ICD-10 Finland

Candidal stomatitis

11.4

213.0

225

205

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

211.8

3105

19089

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

5.3

210.1

442

883

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

5.7

193.1

375

696

A01AB09

ATC

miconazole; local oral

3.3

184.2

801

2713

H02AB06

ATC

prednisolone; systemic

2.2

182.0

3251

21181

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

6.6

179.0

297

472

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.9

161.3

869

3314

B37.04

ICD-10 Finland

Skin-mucous candidal stomatitis

32.0

160.8

104

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

159.3

1669

8708

WZC00

NOMESCO Finland

Treatment plan or consultation

2.1

157.2

2539

15655

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

151.4

1150

5199

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

138.4

2561

16370

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.0

135.7

2095

12548

J01MA12

ATC

levofloxacin; systemic

2.3

134.6

1283

6378

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

134.6

1015

4552

A02BC02

ATC

pantoprazole; systemic

2.0

132.5

4284

32908

EKA10

NOMESCO Finland

iopsy of buccal mucosa

5.3

127.9

264

516

N02AX02

ATC

tramadol; systemic, rectal

1.9

126.2

2719

18124

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

125.6

1368

7158

B37.99

ICD-10 Finland

Candida infection, unspecified

41.6

122.8

H02AB04

ATC

methylprednisolone; systemic

2.3

120.6

1067

5117

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

120.5

1121

5492

N03AX16

ATC

[U] pregabalin

2.1

119.3

1589

8948

J01MA02

ATC

ciprofloxacin; systemic

1.9

118.3

2438

15921

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

118.2

712

2855

C03CA01

ATC

furosemide; systemic

2.0

118.2

1769

10381

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.4

117.5

455

1422

R03BB04

ATC

tiotropium bromide; inhalant

2.7

116.4

721

2931

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

6.1

116.1

205

346

J01FF01

ATC

clindamycin; systemic

2.0

115.1

1807

10763

L43.8

ICD-10 Finland

Other lichen planus

5.6

113.0

217

397

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.5

112.2

402

1195

N02AA05

ATC

oxycodone; systemic

2.2

112.2

1139

5767

R50.9

ICD-10 Finland

Fever, unspecified

2.2

110.3

1055

5211

A02BC05

ATC

esomeprazole; systemic

1.8

110.3

2608

17674

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

3.4

110.0

418

1290

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.0

106.6

1517

8695

UJF32

NOMESCO Finland

Coloscopy

2.0

106.5

1667

9874

SAA03

NOMESCO Finland

Extended examination of mouth

1.8

106.3

2561

17396

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

5.5

105.5

207

386

K13.78

ICD-10 Finland

Other change in the oral mucosa

4.5

105.3

264

607

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

104.9

467

1586

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.3

103.8

405

1270

R06.0

ICD-10 Finland

Dyspnoea

1.9

103.6

1727

10430

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.8

101.8

542

2032

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

100.8

1320

7328

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

100.6

2663

18509

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.9

100.6

308

822

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

98.9

1266

6966

127

Kela drug reimbursment

Transplant complication

6.3

98.8

168

273

R13

ICD-10 Finland

Dysphagia

2.8

98.7

542

2065

L04AA06

ATC

mycophenolic acid; systemic

5.4

97.6

197

377

E0000UV, ,

ATC

1.8

97.4

2668

18674

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

97.3

1276

7076

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.7

96.4

571

2261

A01AB04

ATC

amphotericin B; local oral

3.3

96.3

381

1204

N76.8

ICD-10 Finland

Other specified inflammation of vagina and vulva

5.2

96.3

202

400

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

94.2

1487

8776

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.3

93.8

808

3802

J01DB01

ATC

cefalexin; oral

2.1

92.8

5070

43270

N76.0

ICD-10 Finland

Acute vaginitis

2.6

92.1

568

2293

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

91.8

1473

8728

P01AB01

ATC

metronidazole; oral, rectal

1.7

91.6

2563

17954

A63.0

ICD-10 Finland

Anogenital (venereal) warts

3.4

91.0

344

1056

N51.2*B37.4

ICD-10 Finland

Candidal balanitis

32.5

90.0

B37.02

ICD-10 Finland

Chronic hyperplastic candidal stomatitis

159.1

89.3

AA1AD

NOMESCO Finland

CT of head and brain

1.8

88.4

1633

10103

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

87.6

878

4388

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

87.1

1631

10125

H02AB07

ATC

prednisone; oral

2.1

85.9

927

4765

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

85.1

2049

13681

SAA04

NOMESCO Finland

Special examination of mouth

2.9

85.1

421

1514

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

84.9

1050

5673

N05BA04

ATC

oxazepam; oral

1.8

84.5

1698

10753

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

84.3

691

3175

N06AX11

ATC

mirtazapine; oral

1.7

83.4

2133

14467

GD1AD

NOMESCO Finland

Thorax CT examination

2.9

82.5

414

1500

TGC00

NOMESCO Finland

Bronchial lavation

4.3

81.0

215

516

A41.9

ICD-10 Finland

Sepsis, unspecified

3.6

80.9

278

802

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

80.6

1193

6847

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

80.0

523

2167

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

79.9

926

4877

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

79.2

755

3690

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

78.7

771

3808

J01MA14

ATC

moxifloxacin; systemic

2.4

78.4

614

2762

R03AC02

ATC

salbutamol; inhalant

1.7

77.6

3373

26140

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

77.1

913

4843

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.3

76.9

641

2961

K13.29

ICD-10 Finland

Indefinite leukoplakia

6.0

76.9

137

233

L04AX01

ATC

azathioprine; systemic

3.1

76.5

339

1144

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.9

76.5

228

596

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

76.3

678

3217

R11

ICD-10 Finland

Nausea and vomiting

2.3

76.3

628

2886

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

76.1

670

3167

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

76.0

853

4434

L43.9

ICD-10 Finland

Lichen planus, unspecified

4.4

75.9

193

448

J02AC02

ATC

itraconazole; systemic

1.9

75.8

1152

6656

K11.70

ICD-10 Finland

Hypoptyalism

9.4

75.4

ECA20

NOMESCO Finland

Biopsy of gingiva

6.2

75.0

129

212

N05CF01

ATC

zopiclone; oral

1.7

74.8

1936

13084

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

74.7

813

4176

K13.20

ICD-10 Finland

Idiopathic leukoplakia

11.7

73.1

JDB10

NOMESCO Finland

Percutaneous gastrostomy

6.5

73.1

120

188

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

73.0

719

3553

J05AB01

ATC

aciclovir; systemic

1.8

72.7

1410

8772

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

72.5

1292

7835

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

72.5

3176

24486

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

72.3

1662

10853

R03DC03

ATC

montelukast; oral

1.9

72.3

1103

6369

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

72.1

1320

8070

N30.0

ICD-10 Finland

Acute cystitis

1.9

71.9

1127

6564

A02BC01

ATC

omeprazole; systemic

1.7

71.5

1675

10990

R53

ICD-10 Finland

Malaise and fatigue

1.8

71.2

1522

9732

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

71.1

878

4717

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.8

70.7

162

346

K12.10

ICD-10 Finland

Stomatitis NOS

8.5

70.3

109

D07AC01

ATC

betamethasone; topical

1.7

70.1

2159

15211

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.8

69.6

368

1369

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

69.1

1595

10405

JN4AD

NOMESCO Finland

Body CT examination

2.2

68.9

624

2978

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

68.9

621

2958

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

68.6

633

3045

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

68.5

2659

19807

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.0

68.2

319

1110

EHA10

NOMESCO Finland

Biopsy of palate

8.1

67.7

114

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

5.7

67.7

127

227

A10AB05

ATC

insulin aspart; parenteral

2.4

67.6

500

2188

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.3

67.4

260

807

UKC02

NOMESCO Finland

Cystoscopy

2.0

67.0

894

4928

K12.18

ICD-10 Finland

Other forms of stomatitis

7.2

66.8

139

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

66.6

1152

6901

N06AB04

ATC

citalopram; systemic

1.8

66.6

1328

8300

A06AD11

ATC

lactulose; oral

2.0

66.4

869

4756

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

66.4

542

2476

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

3.9

66.4

196

509

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.0

66.3

301

1029

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

64.6

596

2863

A02BC03

ATC

lansoprazole; oral

1.7

64.3

1677

11268

L04AD01

ATC

ciclosporin; systemic

4.3

63.9

167

396

A10AE04

ATC

insulin glargine; parenteral

2.2

63.9

586

2808

A46

ICD-10 Finland

Erysipelas

2.0

63.9

831

4535

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.4

63.8

453

1945

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.2

63.2

594

2874

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

63.2

388

1556

N03AX12

ATC

[U] gabapentin; oral

1.8

62.9

1021

5987

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.5

62.7

220

643

R06AE07

ATC

cetirizine; oral

1.6

62.6

2708

20548

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

62.0

750

3987

ZXD05

NOMESCO Finland

Urgent procedure

1.6

62.0

1847

12814

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

61.9

1569

10446

D07AD01

ATC

clobetasol; topical

1.8

61.2

1038

6167

N05AH04

ATC

quetiapine; oral

1.8

61.1

1094

6605

N02BE01

ATC

paracetamol; systemic, rectal

1.9

60.9

5300

47575

WW500

NOMESCO Finland

Blood transfusion

2.9

60.9

297

1057

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.5

60.8

405

1688

R03BA05

ATC

fluticasone; inhalant

1.8

60.5

1147

7041

WX892

NOMESCO Finland

Monitored bed care

2.3

60.4

477

2146

J45

ICD-10 Finland

Asthma

2.0

60.1

690

3598

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.5

59.4

407

1718

J01EA01

ATC

trimethoprim; systemic

1.6

59.0

1652

11258

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

58.7

654

3372

R02

ICPC

Shortness of breath/dyspnoea

1.9

58.5

813

4529

JN4BD

NOMESCO Finland

Extensive body CT

2.1

58.2

624

3172

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.6

58.2

195

553

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

58.1

524

2491

J01DA01

ATC

[U] cefalexin

1.6

57.9

3623

29650

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

57.2

628

3219

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.9

57.2

127

264

R51.80

ICD-10 Finland

Headache

1.8

57.1

1016

6112

SPAT1262

SPAT

Handing over of treatment supplies

1.8

57.0

1008

6052

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

56.8

1525

10265

H02AB09

ATC

hydrocortisone; systemic

3.5

56.4

196

569

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

56.2

611

3121

SXA10

NOMESCO Finland

Oral mucosal sampling

4.9

56.1

124

257

A02BA02

ATC

ranitidine; systemic

1.7

55.6

1112

6915

J05AB11

ATC

valaciclovir; oral

1.8

55.5

908

5320

J01FA06

ATC

roxithromycin; oral

1.6

55.3

2334

17455

J01AA02

ATC

doxycycline; systemic

1.6

55.3

4521

39111

SPAT1254

SPAT

Administration of medicine

1.8

55.2

881

5122

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

54.9

817

4646

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.3

53.7

442

2022

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.8

53.6

277

1016

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

53.4

1725

12118

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

53.3

261

930

N06AX16

ATC

venlafaxine; oral

1.8

53.3

906

5367

R60.0

ICD-10 Finland

Localized oedema

1.9

52.7

721

3986

J46

ICD-10 Finland

Status asthmaticus

3.1

52.6

222

727

XG410

NOMESCO Finland

Flow-volume spirometry

2.8

52.6

268

976

N06AX21

ATC

duloxetine; oral

1.9

52.5

749

4199

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

51.8

642

3431

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.1

51.4

529

2643

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.6

51.4

303

1189

E000001, ,

ATC

1.7

51.4

1193

7707

TK800

NOMESCO Finland

Hemodialysis

3.9

50.9

152

398

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

50.8

559

2863

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

50.6

4180

35790

N06AA09

ATC

amitriptyline; systemic

2.0

50.5

598

3144

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.7

50.5

274

1031

XQ800

NOMESCO Finland

Prick test

2.1

50.5

508

2517

L04AD02

ATC

tacrolimus; systemic

5.7

49.7

166

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.5

49.7

321

1317

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

49.6

1397

9468

SPF20

NOMESCO Finland

Temporary relining of dentures

5.7

49.5

163

B37.9

ICD-10 Finland

Candidiasis, unspecified

491.9

49.4

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

49.4

2920

23266

SPF30

NOMESCO Finland

Relining of denture

4.0

49.1

143

368

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

49.0

1244

8211

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

9.4

48.9

S18

ICPC

Laceration/cut

1.5

48.8

2520

19521

L17

ICPC

Foot/toe symptom/complaint

1.6

48.7

1653

11697

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

48.5

284

1111

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

48.5

785

4572

R03BA02

ATC

budesonide; inhalant

1.7

48.4

1073

6837

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.7

48.3

152

413

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

48.1

4212

36286

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

48.0

1291

8641

WX002

NOMESCO Finland

Sedation and analgesia

1.7

48.0

1103

7093

R96

ICPC

Asthma

1.9

47.8

611

3296

SPAT1255

SPAT

Intravenous administration of medicine

2.2

47.6

422

1988

S97

ICPC

Chronic ulcer skin

2.4

47.6

350

1524

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.8

47.4

247

910

SPAT1263

SPAT

Sampling

1.5

47.3

2442

18875

GBB00

NOMESCO Finland

Tracheostomy

5.0

47.1

101

204

A41.8

ICD-10 Finland

Other specified sepsis

3.9

46.9

137

353

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

46.8

1073

6889

ZX120

NOMESCO Finland

Intravenous

2.0

46.6

563

2978

R03AC13

ATC

formoterol; inhalant

2.4

46.4

338

1465

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

46.4

385

1765

Z2446

NOMESCO Finland

Social worker

2.2

46.3

423

2016

M79.6

ICD-10 Finland

Pain in limb

1.5

46.3

2414

18671

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

46.1

340

1482

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.6

45.8

281

1124

N05CD07

ATC

temazepam; oral

1.9

45.5

645

3598

R01AD09

ATC

mometasone; nasal

1.5

45.5

2682

21230

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

45.5

625

3452

SBB10

NOMESCO Finland

Dental impressions

2.2

45.4

428

2065

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.0

45.3

208

715

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

45.2

857

5220

R03BA08

ATC

ciclesonide; inhalant

2.0

45.1

542

2861

TEA00

NOMESCO Finland

Biopsy of lip

5.0

45.0

193

A04

ICPC

Weakness/tiredness general

1.7

44.5

897

5556

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.6

44.5

268

1063

Z01.2

ICD-10 Finland

Dental examination

1.5

44.3

2646

20963

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

44.3

610

3371

M54.5

ICD-10 Finland

Low back pain

1.5

44.1

2082

15740

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

44.1

481

2452

R03AK08

ATC

formoterol and beclometasone; inhalant

2.5

44.0

300

1261

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

44.0

2415

18813

B37

ICD-10 Finland

Candidiasis

11.3

44.0

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

3.0

43.7

193

649

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

43.7

220

796

EJ2S1

NOMESCO Finland

Photography of oral mucosa

5.8

43.7

140

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.3

43.5

353

1603

J01FA10

ATC

azithromycin; systemic

1.5

43.4

3356

27889

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.9

43.3

203

706

Z3226

NOMESCO Finland

Physiotherapist

1.7

43.3

1052

6844

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

43.3

488

2518

J20

ICD-10 Finland

Acute bronchitis

1.9

43.2

618

3455

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

43.2

417

2030

C07AB07

ATC

bisoprolol; oral

1.5

42.8

2529

19951

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

2.5

42.5

273

1116

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

42.4

843

5197

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

42.4

1706

12458

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

42.4

2376

18544

A10AC01

ATC

insulin (human); parenteral

2.1

42.2

440

2205

G44.2

ICD-10 Finland

Tension-type headache

1.7

42.1

846

5232

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

42.1

381

1809

N30.9

ICD-10 Finland

Cystitis, unspecified

2.1

42.1

404

1963

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.7

42.0

231

875

N05AH03

ATC

olanzapine; systemic

2.2

41.9

382

1819

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

41.8

477

2470

XQ802

NOMESCO Finland

Epicutan test

2.4

41.7

290

1230

WX872

NOMESCO Finland

Intensive care

2.4

41.7

294

1255

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

41.7

636

3628

R05

ICD-10 Finland

Cough

1.6

41.4

1233

8417

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

41.4

381

1820

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

41.3

288

1223

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.7

41.3

131

358

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.9

41.3

196

687

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

40.9

1668

12196

R21

ICPC

Throat symptom/complaint

1.6

40.9

1284

8869

J37.0

ICD-10 Finland

Chronic laryngitis

2.7

40.9

228

870

Z3231

NOMESCO Finland

Registered nurse

1.5

40.9

1512

10832

A04AA01

ATC

ondansetron; systemic, rectal

2.0

40.7

487

2564

R03BA01

ATC

beclometasone; inhalant

1.7

40.6

821

5082

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.0

40.5

114

286

N05AA02

ATC

levomepromazine; systemic

2.6

40.4

248

992

L04AX03

ATC

methotrexate; systemic

1.9

40.2

578

3235

K13.28

ICD-10 Finland

Other leukoplakia or disorder of epithelium of the palate or tongue

8.2

40.1

R68.2

ICD-10 Finland

Dry mouth, unspecified

5.7

39.9

131

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

13.8

39.9

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

39.9

302

1331

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

4.5

39.8

218

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

39.6

460

2396

1121A

ICD-9 Finland

Candidiasis, Of vulva and vagina

+∞

39.6

R01AD08

ATC

fluticasone; nasal

1.5

39.6

1661

12204

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

39.4

1195

8180

L04AA01

ATC

[U] ciclosporin

4.1

39.3

107

262

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.3

39.3

306

1365

SPAT1229

SPAT

Assessment of need for aid

2.0

39.2

442

2278

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.2

39.2

354

1679

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.9

39.1

191

680

R42

ICD-10 Finland

Dizziness and giddiness

1.6

39.1

1267

8806

L28

ICPC

Limited function/disability (L)

1.6

39.0

951

6176

R03AC12

ATC

salmeterol; inhalant

2.4

38.9

280

1207

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

38.6

1600

11716

A11CC03

ATC

alfacalcidol; systemic

3.2

38.5

156

499

J01CA08

ATC

pivmecillinam; oral

1.4

38.4

2503

19977

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

38.4

167

557

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.4

38.3

142

430

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

38.3

645

3786

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

38.3

519

2849

U07

ICPC

Urine symptom/complaint other

2.0

38.2

447

2333

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

38.1

243

990

A10AE05

ATC

insulin detemir; parenteral

2.3

37.9

314

1437

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

37.9

896

5771

R52.9

ICD-10 Finland

Pain, unspecified

1.8

37.9

578

3293

N05BA01

ATC

diazepam; systemic, rectal

1.7

37.7

731

4467

R4190

NOMESCO Finland

Nutritional therapy

2.5

37.7

236

954

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

37.6

662

3936

SPAT1301

SPAT

No procedures

1.5

37.6

1733

12948

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

37.6

334

1573

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

5.0

37.4

165

WZC30

NOMESCO Finland

Teaching

1.7

37.4

859

5491

R33

ICD-10 Finland

Retention of urine

2.0

37.1

395

1994

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.5

37.0

247

1028

Z94.0

ICD-10 Finland

Kidney transplant status

4.6

37.0

194

A03FA02

ATC

cisapride; oral, rectal

2.0

37.0

427

2219

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.3

37.0

139

425

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

36.9

527

2939

K92.1

ICD-10 Finland

Melaena

2.3

36.9

296

1336

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.6

36.9

120

334

D01

ICPC

Abdominal pain/cramps general

1.7

36.8

712

4348

N06AB03

ATC

fluoxetine; oral

1.7

36.7

717

4389

B37.06

ICD-10 Finland

Candidal cheilitis

49.2

36.6

J01CA04

ATC

amoxicillin; systemic

1.5

36.4

4778

43131

S29

ICPC

Skin symptom/complaint other

1.6

36.4

1077

7316

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

36.1

1574

11611

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.5

36.0

239

992

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

4.3

36.0

219

SXC05

NOMESCO Finland

Other oral or dental procedure

2.0

36.0

398

2036

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

35.7

613

3615

A07AA09

ATC

vancomycin; oral

3.9

35.5

106

278

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.3

35.5

138

431

K14.61

ICD-10 Finland

Glossodynia

4.6

35.4

181

K13.22

ICD-10 Finland

Erythroplakia of oral epithelium, including tongue

10.1

35.3

N06AB10

ATC

escitalopram; oral

1.5

35.2

1200

8408

G47.3

ICD-10 Finland

Sleep apnoea

1.5

35.1

1141

7909

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

35.1

1304

9305

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.1

35.0

241

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

35.0

3842

33374

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

35.0

714

4420

UJD02

NOMESCO Finland

Gastroscopy

2.3

34.9

283

1283

A07EA06

ATC

budesonide; oral, local oral

2.5

34.9

231

958

K02.1

ICD-10 Finland

Caries of dentine

1.4

34.9

3336

28287

Z2221

NOMESCO Finland

Medical doctor

1.5

34.9

1557

11528

SXC03

NOMESCO Finland

Other oral or dental procedure

4.2

34.8

225

J01MA06

ATC

norfloxacin; oral

1.7

34.8

752

4727

R07.3

ICD-10 Finland

Other chest pain

1.8

34.7

574

3349

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.3

34.6

134

417

K22.2

ICD-10 Finland

Oesophageal obstruction

5.1

34.6

142

TJD20

NOMESCO Finland

Change of gastrostomy tube

8.1

34.6

M03BX02

ATC

tizanidine; oral

1.4

34.5

3504

29994

B01AB05

ATC

enoxaparin; parenteral

1.5

34.4

1689

12728

R51

ICD-10 Finland

Headache

2.1

34.3

357

1787

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

34.2

917

6079

M01AE02

ATC

naproxen; oral, rectal

1.4

34.2

3223

27222

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

34.2

636

3837

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

34.2

515

2920

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

34.2

524

2987

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

34.0

1139

7942

A28

ICPC

Limited function/disability NOS

1.6

34.0

859

5615

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.6

33.7

112

316

N03AX09

ATC

lamotrigine; oral

2.2

33.7

300

1414

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

33.7

352

1764

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

33.7

408

2155

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

33.6

1494

11041

N77.1

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere

3.9

33.5

249

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

33.4

2634

21560

V03AE01

ATC

polystyrene sulfonate; oral

4.2

33.3

211

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

33.2

394

2065

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

33.1

849

5564

A12AA04

ATC

calcium carbonate; oral

3.7

33.1

106

292

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.3

33.1

248

1088

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

33.0

485

2727

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

33.0

1965

15316

A10AB04

ATC

insulin lispro; parenteral

2.6

33.0

198

784

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.1

33.0

140

461

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

32.9

281

1302

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

32.9

193

756

ZY010

NOMESCO Finland

Hospital outpatient

2.1

32.8

315

1528

A02BC04

ATC

rabeprazole; oral

1.8

32.8

511

2925

R4110

NOMESCO Finland

Physiotherapy

1.5

32.8

1484

10992

Z51.5

ICD-10 Finland

Palliative care

1.9

32.8

402

2131

J47

ICD-10 Finland

Bronchiectasis

3.4

32.8

120

361

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

32.8

469

2616

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.6

32.7

198

787

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

32.7

1687

12808

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

32.7

950

6413

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

32.6

480

2701

EJB10

NOMESCO Finland

Excision of tumor or other lesion of apex or body of tongue

6.2

32.5

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

32.5

242

1058

N06AB06

ATC

sertraline; oral

1.7

32.4

662

4095

X58

ICD-10 Finland

Exposure to other specified factors

1.6

32.3

763

4901

D01AC02

ATC

miconazole; topical

1.9

32.2

408

2187

N03AG01

ATC

valproic acid; systemic, rectal

2.0

32.2

343

1731

T89

ICPC

Diabetes insulin dependent

2.3

32.2

238

1038

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.0

32.1

140

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

32.0

504

2894

SPAT1260

SPAT

Consultation of another employee

1.6

31.9

973

6636

Z71.8

ICD-10 Finland

Other specified counselling

1.4

31.9

1737

13307

M79.1

ICD-10 Finland

Myalgia

1.6

31.9

839

5530

N02BF01

ATC

gabapentin; oral

1.8

31.8

469

2639

A01

ICPC

Pain general/multiple sites

1.8

31.8

526

3066

B03XA02

ATC

darbepoetin alfa; parenteral

3.1

31.7

133

435

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.4

31.6

218

921

EBB10

NOMESCO Finland

Insertion of dental implant

3.5

31.6

108

311

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.3

31.5

257

1168

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

31.5

468

2640

T90

ICPC

Diabetes non-insulin dependent

1.5

31.5

1164

8272

L43.3

ICD-10 Finland

Subacute (active) lichen planus

9.5

31.5

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

31.5

393

2096

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.6

31.3

178

686

L30.4

ICD-10 Finland

Erythema intertrigo

3.7

31.3

100

275

E000006, ,

ATC

1.9

31.3

401

2158

N03AE01

ATC

clonazepam; systemic

2.0

31.2

341

1736

N05CF02

ATC

zolpidem; oral

1.5

31.2

978

6709

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.1

31.0

131

430

WYA10

NOMESCO Finland

Emergency care or similar visit

1.9

31.0

447

2498

N01

ICPC

Headache

1.7

31.0

652

4062

SPAT1312

SPAT

General health counselling

1.4

30.9

1773

13697

E87.6

ICD-10 Finland

Hypokalaemia

2.5

30.8

201

829

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

6.3

30.7

J01MA01

ATC

ofloxacin; systemic

1.9

30.7

441

2462

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

30.6

465

2641

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

30.6

313

1556

XKD00

NOMESCO Finland

Uroflowmetry

1.7

30.5

665

4180

SFA10

NOMESCO Finland

One-surface restoration

1.4

30.5

3068

25979

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

30.4

612

3769

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

30.3

980

6764

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.1

30.3

126

410

B37.1

ICD-10 Finland

Pulmonary candidiasis

+∞

30.2

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.0

30.2

339

1742

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

30.2

285

1374

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.1

30.1

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

30.1

693

4417

J01DA09

ATC

[U] cefadroxil

1.4

30.1

1440

10753

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

30.1

557

3351

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

30.0

258

1198

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

30.0

401

2187

L03

ICPC

Low back symptom/complaint

1.4

29.8

1553

11773

R03DA04

ATC

theophylline; systemic, rectal

2.2

29.8

272

1294

D07AA02

ATC

hydrocortisone; topical

1.6

29.6

784

5168

K20

ICD-10 Finland

Oesophagitis

3.2

29.6

117

369

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

29.6

293

1438

K23.8

ICD-10 Finland

Disorders of oesophagus in other diseases classified elsewhere

34.8

29.6

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.5

29.6

100

286

J01FA09

ATC

clarithromycin; systemic

1.4

29.4

1714

13250

N48.1

ICD-10 Finland

Balanoposthitis

3.0

29.4

128

428

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

29.4

722

4676

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

29.4

353

1858

M02AA07

ATC

piroxicam; topical

1.4

29.3

1885

14816

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

29.3

282

1369

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

29.3

641

4031

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.2

29.3

184

S02

ICPC

Pruritus

2.3

29.3

217

947

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.5

29.3

183

739

K30

ICD-10 Finland

Functional dyspepsia

1.7

29.2

646

4073

M25.5

ICD-10 Finland

Pain in joint

1.4

29.2

1771

13782

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

29.2

318

1617

SPF10

NOMESCO Finland

Demanding reparation of dental prosthesis

3.2

29.1

118

378

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.3

29.1

112

348

K59.0

ICD-10 Finland

Constipation

2.0

29.1

315

1599

N07BB01

ATC

disulfiram; oral

2.3

29.0

224

996

K92.0

ICD-10 Finland

Haematemesis

2.9

28.9

141

502

EDB00

NOMESCO Finland

Partial excision of mandible

10.4

28.9

R05

ICPC

Cough

1.4

28.9

1338

9920

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

28.8

559

3406

N05BB01

ATC

hydroxyzine; systemic

1.9

28.7

357

1900

A07EC02

ATC

mesalazine; oral, rectal

2.0

28.7

302

1516

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.1

28.6

123

408

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

28.6

3052

25969

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

5.5

28.6

101

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.0

28.6

123

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

8.1

28.6

G01AA10

ATC

clindamycin; vaginal

1.6

28.6

865

5879

C10AC01

ATC

colestyramine; oral

2.6

28.5

171

677

A01AB10

ATC

natamycin; local oral

2.5

28.5

187

773

D07AC13

ATC

mometasone; topical

1.4

28.4

1542

11760

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

28.4

928

6412

R74

ICPC

Upper respiratory infection acute

1.4

28.4

1812

14210

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

28.4

1139

8211

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.9

28.3

375

2038

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.7

28.3

151

564

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.7

28.3

247

NHQ40

NOMESCO Finland

Amputation of toe

3.7

28.3

247

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

28.3

1284

9479

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

28.2

390

2149

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

3.0

28.2

125

422

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

28.2

513

3070

W19

ICD-10 Finland

Unspecified fall

1.7

28.2

513

3070

SPAT1216

SPAT

Assessment of functional ability

1.6

28.0

782

5216

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

27.9

162

631

R03AC03

ATC

terbutaline; inhalant

1.6

27.9

782

5220

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.6

27.9

686

4440

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.7

27.8

236

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.4

27.8

192

813

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.4

27.8

101

303

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

27.8

362

1958

N30

ICD-10 Finland

Cystitis

1.7

27.5

488

2899

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.9

27.5

348

1864

A10BH01

ATC

sitagliptin; oral

1.8

27.4

472

2781

SPAT1234

SPAT

Support of social functional capacity

2.1

27.4

279

1385

K08.80

ICD-10 Finland

Toothache NOS

1.7

27.3

501

3004

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

27.3

251

1198

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

27.2

699

4570

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

27.2

239

1120

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

27.2

306

1574

K03.66

ICD-10 Finland

Tooth plaque

1.8

27.1

408

2309

XG466

NOMESCO Finland

Sleep oxymetry

2.5

27.0

174

713

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

27.0

1470

11199

N05BA12

ATC

alprazolam; oral

1.7

26.9

553

3420

C03DA01

ATC

spironolactone; oral

1.7

26.9

579

3624

H03AA01

ATC

levothyroxine sodium; systemic

1.4

26.9

1320

9873

L01BA01

ATC

methotrexate; systemic

2.2

26.8

219

996

SPA10

NOMESCO Finland

Setting attachments on tooth or implanted bracket or imblant based structures

8.0

26.8

J01CF05

ATC

flucloxacillin; systemic

1.9

26.8

336

1793

P01BA02

ATC

hydroxychloroquine; oral

1.8

26.8

467

2760

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

26.8

560

3479

D07AB08

ATC

desonide; topical

1.6

26.7

593

3739

R07.0

ICD-10 Finland

Pain in throat

1.8

26.7

412

2349

N05BE01

ATC

buspirone; oral

2.5

26.7

174

717

R52.2

ICD-10 Finland

Other chronic pain

2.2

26.6

223

1025

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.4

26.6

185

785

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.2

26.6

172

D11

ICPC

Diarrhoea

1.6

26.5

674

4394

WX882

NOMESCO Finland

High dependency care

2.6

26.5

159

630

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

26.4

641

4133

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

26.4

632

4062

E86

ICD-10 Finland

Volume depletion

2.8

26.4

137

505

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.7

26.3

138

511

N02BF02

ATC

pregabalin; oral

1.9

26.3

329

1755

SPAT1153

SPAT

Removal of sutures

1.4

26.3

1626

12652

D06BB04

ATC

podophyllotoxin; topical

2.0

26.2

305

1587

R01AD58

ATC

fluticasone, combinations; nasal

1.4

26.2

1365

10310

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

26.2

1126

8210

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

26.2

377

2104

R06AX22

ATC

ebastine; oral

1.5

26.1

955

6744

X15

ICPC

Vaginal symptom/complaint other

2.1

26.1

249

1205

UJC12

NOMESCO Finland

Flexible oesophagoscopy

4.6

26.1

137

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

26.1

342

1853

D06

ICPC

Abdominal pain localized other

1.7

26.1

505

3073

G01AF05

ATC

econazole; vaginal

1.8

26.0

440

2579

TQW80

NOMESCO Finland

Local dermatologic skincare

2.6

25.9

153

602

SPD00

NOMESCO Finland

Mucosa borne complete denture

3.8

25.9

202

SPAT1211

SPAT

Application of soft bandage

1.7

25.8

474

2841

SPD05

NOMESCO Finland

Mucosa borne complete denture, demanding

7.2

25.8

L29.2

ICD-10 Finland

Pruritus vulvae

2.9

25.8

120

417

ULA02

NOMESCO Finland

Kolposcopy

1.7

25.8

558

3496

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

25.8

200

891

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.4

25.7

273

EBB15

NOMESCO Finland

Insertion of dental implant abutment

4.1

25.7

172

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.1

25.7

242

1166

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

25.6

1369

10380

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

25.6

153

605

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.6

25.6

231

R35

ICD-10 Finland

Polyuria

1.9

25.6

338

1836

EBA00

NOMESCO Finland

Extraction of tooth

1.4

25.6

1883

15057

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

25.5

555

3480

R03BB01

ATC

ipratropium bromide; inhalant

2.3

25.5

199

888

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

25.5

456

2714

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.8

25.5

127

458

C01DA14

ATC

isosorbide mononitrate; oral

1.6

25.5

671

4411

C07AA05

ATC

propranolol; systemic

1.4

25.4

1121

8208

R04.2

ICD-10 Finland

Haemoptysis

2.4

25.4

176

746

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.2

25.4

213

980

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

25.3

412

2386

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.0

25.3

274

1391

K29.7

ICD-10 Finland

Gastritis, unspecified

2.2

25.3

206

937

L29.9

ICD-10 Finland

Pruritus, unspecified

2.5

25.3

166

687

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

25.2

275

1399

R10.0

ICD-10 Finland

Acute abdomen

2.3

25.2

196

874

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.5

25.2

159

646

U02

ICPC

Urinary frequency/urgency

1.5

25.1

792

5421

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

25.0

996

7149

SPAT1325

SPAT

Vaccination

1.4

25.0

1734

13721

SPAT1310

SPAT

Counselling related to known health issue

1.4

25.0

1714

13543

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

24.9

292

1523

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

24.9

226

1073

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

24.8

501

3081

F34.1

ICD-10 Finland

Dysthymia

2.2

24.8

221

1042

N18.8

ICD-10 Finland

Other chronic renal failure

2.7

24.8

130

482

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

2.2

24.7

206

945

D07XC01

ATC

betamethasone; topical

1.6

24.7

609

3938

ZXA05

NOMESCO Finland

Left side

1.4

24.6

1230

9207

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

2.5

24.6

157

641

L03AA02

ATC

filgrastim; parenteral

2.4

24.5

169

715

B35.3

ICD-10 Finland

Tinea pedis

2.2

24.5

214

1001

ZXA10

NOMESCO Finland

Bilateral

1.5

24.5

949

6774

R03DC01

ATC

zafirlukast; oral

3.1

24.5

102

333

C05AA08

ATC

fluocortolone; rectal, topical

1.6

24.4

709

4764

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.6

24.4

141

549

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

24.4

373

2121

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.7

24.3

135

515

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

24.2

385

2215

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

24.1

243

1201

M48.0

ICD-10 Finland

Spinal stenosis

1.6

24.0

591

3819

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

24.0

407

2384

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.8

24.0

199

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.1

24.0

316

M04AA01

ATC

allopurinol; systemic

1.6

24.0

571

3662

JAH00

NOMESCO Finland

Laparotomy

2.5

23.9

151

614

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

23.9

463

2817

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

23.8

1584

12438

L43.0

ICD-10 Finland

Hypertrophic lichen planus

4.9

23.6

104

R01AD11

ATC

triamcinolone; nasal

1.7

23.6

478

2943

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

23.5

369

2113

P01

ICPC

Feeling anxious/nervous/tense

1.6

23.5

685

4603

N06AA12

ATC

doxepin; systemic

2.0

23.5

271

1407

L02

ICPC

Back symptom/complaint

1.6

23.5

554

3545

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

23.4

1204

9052

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

6.0

23.4

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

23.3

155

645

K14.60

ICD-10 Finland

Glossopyrosis

4.6

23.3

121

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.1

23.3

233

1149

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.1

23.2

317

A02BA03

ATC

famotidine; systemic

2.2

23.2

193

885

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.0

23.2

100

333

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.3

23.2

179

796

R06AX27

ATC

desloratadine; oral

1.4

23.2

1580

12442

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

23.1

260

1337

U05

ICPC

Urination problems other

2.0

23.1

264

1366

SPAT1104

SPAT

Monitoring of emergency patient

1.8

23.1

350

1985

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

23.1

1002

7304

G01AF04

ATC

miconazole; vaginal

1.9

23.0

280

1480

KCV04

NOMESCO Finland

Distension of bladder with fluid

3.8

22.9

187

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.9

22.9

288

1538

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

22.9

3797

33924

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

22.9

1922

15618

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

4.7

22.8

111

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.7

22.8

412

2457

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.6

22.8

115

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

22.8

366

2111

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.8

22.8

115

418

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

22.8

1079

7989

SPAT1240

SPAT

Therapeutic discussion

1.6

22.7

590

3860

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

5.3

22.7

N06AX12

ATC

bupropion; oral

1.8

22.7

387

2272

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

22.6

291

1566

D02AE01

ATC

carbamide; topical

1.8

22.6

345

1959

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

22.6

707

4825

UJF92

NOMESCO Finland

Capsular endoscopy

2.6

22.5

129

500

J45.8

ICD-10 Finland

Mixed asthma

2.3

22.5

179

806

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.9

22.5

108

382

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.9

22.5

103

355

S76

ICPC

Skin infection other

1.9

22.5

282

1506

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

22.4

695

4731

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

22.4

532

3408

E87.5

ICD-10 Finland

Hyperkalaemia

3.0

22.4

319

A10AB01

ATC

insulin (human); parenteral

2.2

22.4

191

886

K07.60

ICD-10 Finland

Snapping jaw

1.9

22.3

306

1681

N76.3

ICD-10 Finland

Subacute and chronic vulvitis

3.4

22.3

238

WW200

NOMESCO Finland

Immunization

2.4

22.3

154

652

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

22.3

315

1747

P76

ICPC

Depressive disorder

1.8

22.3

365

2117

C07AB02

ATC

metoprolol; systemic

1.4

22.3

945

6853

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.0

22.3

L01

ICPC

Neck symptom/complaint

1.5

22.3

855

6083

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

22.3

242

1230

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

22.3

729

5022

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

5.8

22.2

M05BX04

ATC

denosumab; parenteral

1.8

22.2

314

1742

G04CA02

ATC

tamsulosin; oral

1.5

22.2

875

6256

D01BA02

ATC

terbinafine; oral

1.4

22.2

1209

9167

RD210, ,

NOMESCO Finland

2.8

22.1

113

414

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

7.1

22.0

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

22.0

229

1146

RS221, ,

NOMESCO Finland

3.1

21.9

307

SBA10

NOMESCO Finland

Measurement of salivary flow rate

3.5

21.9

217

130

Kela drug reimbursment

Malignant tumour

1.7

21.9

410

2471

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

21.8

257

1343

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

21.8

1349

10444

GD6AD

NOMESCO Finland

CT of chest and neck

6.3

21.8

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

21.7

329

1865

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

21.7

326

1843

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

4.4

21.7

120

ZZA00

NOMESCO Finland

Split skin graft

2.4

21.7

148

624

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

21.6

547

3556

H62.2*B37.2

ICD-10 Finland

Otitis externa in candidiasis

220.8

21.6

A10BA02

ATC

metformin; oral

1.4

21.6

1335

10331

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

21.6

281

1519

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.9

21.5

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.5

21.5

140

578

C01CA24

ATC

epinephrine; parenteral

1.8

21.5

354

2058

K12.12

ICD-10 Finland

Stomatitis ulcerative

4.7

21.4

105

J01XX08

ATC

linezolid; systemic

4.6

21.4

109

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.8

21.4

109

398

N05AN01

ATC

lithium; oral

2.5

21.4

139

573

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

21.4

2128

17673

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.1

21.3

205

996

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.0

21.3

241

1243

EB1WA, ,

NOMESCO Finland

4.4

21.2

122

N06AX05

ATC

trazodone; oral

2.3

21.2

154

667

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

3.3

21.2

241

J96.0

ICD-10 Finland

Acute respiratory failure

3.5

21.2

212

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

21.2

199

959

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

21.1

604

4040

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

21.0

282

1539

A03

ICPC

Fever

1.4

21.0

904

6568

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

21.0

173

791

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.2

21.0

258

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.3

21.0

238

A10BB12

ATC

glimepiride; oral

1.8

20.9

295

1635

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

20.9

201

976

U01

ICPC

Dysuria/painful urination

1.7

20.9

442

2748

B01AA03

ATC

warfarin; systemic

1.5

20.9

820

5853

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.3

20.9

166

748

R30.0

ICD-10 Finland

Dysuria

2.0

20.8

239

1239

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

6.8

20.8

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

20.7

163

731

SPAT1172

SPAT

Guidance concerning hydration

2.6

20.7

118

457

M02AA10

ATC

ketoprofen; topical

1.5

20.6

811

5793

J02AC03

ATC

voriconazole; systemic

15.8

20.5

R03AK11

ATC

formoterol and fluticasone; inhalant

2.3

20.5

148

640

EBB11

NOMESCO Finland

Insertion of additional dental implant in one session

4.1

20.5

134

137

Kela drug reimbursment

Uraemia requiring dialysis

4.0

20.4

143

E66.8

ICD-10 Finland

Other obesity

1.8

20.4

302

1700

K13.00

ICD-10 Finland

Cheilitis NOS

4.2

20.4

126

J01FA15

ATC

telithromycin; oral

1.6

20.4

508

3291

N05AF03

ATC

chlorprothixene; systemic

2.4

20.4

143

611

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.8

20.3

64091

ICD-8 Finland

Medical termination of pregnancy, Weakness (medical-social reason)

2.0

20.3

227

1166

N17.8

ICD-10 Finland

Other acute renal failure

3.4

20.2

214

L40.8

ICD-10 Finland

Other psoriasis

4.0

20.2

140

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

20.1

320

1840

N03AX11

ATC

topiramate; oral

2.3

20.1

153

677

M01AB05

ATC

diclofenac; systemic, rectal

1.3

20.0

3588

32079

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.9

20.0

324

ZXA00

NOMESCO Finland

Right side

1.4

20.0

1289

10027

SPAT1167

SPAT

Insertion of urinary catheter

2.3

19.9

149

654

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

19.9

905

6635

K13.21

ICD-10 Finland

Leukoplakia caused by tobacco

7.3

19.9

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.3

19.9

120

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

19.9

1839

15079

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.9

19.9

266

1451

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

19.9

326

1892

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.1

19.9

196

962

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

19.8

644

4423

1120A

ICD-9 Finland

Candidiasis, Of mouth[CANDIDIASIS ORALIS]

+∞

19.8

UDM02

NOMESCO Finland

Sinoscopy

2.5

19.8

127

521

B01AC04

ATC

clopidogrel; oral

1.5

19.7

699

4887

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

5.1

19.7

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.2

19.7

171

799

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

19.6

267

1464

SPA20

NOMESCO Finland

Selection and insertion of implant abutment

5.3

19.6

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

19.5

414

2576

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

19.5

1367

10763

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

19.5

508

3324

SPAT1125

SPAT

Stoma care and guidance

2.9

19.5

307

B07.9

ICD-10 Finland

Verruca simplex

2.1

19.5

194

956

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

19.4

353

2108

SFA20

NOMESCO Finland

Two-surface restoration

1.3

19.4

3167

27929

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.3

19.4

114

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.9

19.4

313

H26.3

ICD-10 Finland

Drug-induced cataract

4.4

19.4

110

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

19.3

268

1478

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

19.3

252

1363

P29

ICPC

Psychological sympt/compl other

1.7

19.3

379

2311

U13

ICPC

Bladder symptom/complaint other

2.2

19.3

169

792

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

19.3

255

1385

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.4

19.3

134

570

C08CA01

ATC

amlodipine; oral

1.3

19.3

1788

14655

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.0

19.2

196

974

N06AA10

ATC

nortriptyline; systemic

2.4

19.2

128

535

N06AG02

ATC

moclobemide; oral

2.0

19.1

220

1141

N05AX12

ATC

aripiprazole; systemic

2.0

19.1

212

1086

N06AX03

ATC

mianserin; oral

1.9

19.1

243

1304

M54

ICD-10 Finland

Dorsalgia

1.5

19.1

658

4575

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.8

19.1

338

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

19.0

678

4744

D06BB03

ATC

aciclovir; topical

1.9

19.0

252

1370

M79.7

ICD-10 Finland

Fibromyalgia

2.0

19.0

207

1053

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.8

19.0

297

1700

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.8

19.0

151

X57

ICD-10 Finland

Unspecified privation

2.4

18.9

130

550

F32

ICD-10 Finland

Depressive episode

1.8

18.9

299

1716

L04AA13

ATC

[U] leflunomide

2.3

18.9

143

631

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

18.9

717

5078

K11.2

ICD-10 Finland

Sialoadenitis

2.1

18.9

182

885

A02BA04

ATC

nizatidine; systemic

1.7

18.9

362

2193

K50.8

ICD-10 Finland

Other Crohn disease

2.8

18.9

323

R95

ICPC

Chron obstructive pulmonary disease

2.3

18.9

140

613

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

4.6

18.9

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

18.8

590

4020

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.4

18.8

194

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.7

18.8

100

374

ZXE00

NOMESCO Finland

One hour or less

1.3

18.8

2052

17174

A01AC01

ATC

triamcinolone; local oral

2.7

18.8

101

380

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.6

18.8

106

409

N02AC04

ATC

dextropropoxyphene; oral

2.1

18.8

176

848

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

3.4

18.7

200

X14

ICPC

Vaginal discharge

2.3

18.6

142

629

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.1

18.6

122

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.5

18.6

118

482

H65.2

ICD-10 Finland

Chronic serous otitis media

3.0

18.6

267

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.1

18.6

241

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

18.6

1674

13652

G50.1

ICD-10 Finland

Atypical facial pain

2.6

18.5

109

429

A07EC01

ATC

sulfasalazine; oral, rectal

1.6

18.5

408

2564

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.4

18.5

130

556

D01AA02

ATC

natamycin; topical

2.5

18.5

117

477

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

18.5

180

880

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

18.4

166

787

F05.9

ICD-10 Finland

Delirium, unspecified

2.6

18.4

104

401

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

18.4

707

5018

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

18.4

1400

11141

X72

ICPC

Genital candidiasis female

3.0

18.4

279

K12.00

ICD-10 Finland

Recurrent oral aphthae

2.8

18.4

317

ZX108

NOMESCO Finland

Inhalation

4.1

18.4

119

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

6.4

18.3

A07AA11

ATC

rifaximin; oral

6.4

18.3

H01.0

ICD-10 Finland

Blepharitis

1.7

18.3

346

2088

RS220, ,

NOMESCO Finland

2.9

18.3

285

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

18.3

236

1272

N06AX26

ATC

vortioxetine; oral

1.7

18.3

382

2368

H01

ICPC

Ear pain/earache

1.5

18.3

613

4237

TAB00

NOMESCO Finland

Lumbar puncture

1.9

18.2

239

1295

R01AD12

ATC

fluticasone furoate; nasal

1.3

18.2

1706

13975

H04AA01

ATC

glucagon; nasal, parenteral

2.4

18.2

127

541

SPA02

NOMESCO Finland

Preparation for dental prosthetics

2.1

18.2

163

771

TK810

NOMESCO Finland

Hemofiltration

4.6

18.2

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.7

18.2

364

A03CA02

ATC

clidinium and psycholeptics; oral

1.8

18.1

282

1611

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

18.1

1522

12281

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

18.0

1233

9658

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

18.0

260

1453

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.1

18.0

166

795

A06AC51

ATC

ispaghula, combinations; oral

1.8

18.0

254

1410

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

18.0

1048

8006

L12

ICPC

Hand/finger symptom/complaint

1.4

18.0

824

6044

B01AB04

ATC

dalteparin; parenteral

1.8

18.0

266

1498

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

17.9

852

6289

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

17.9

258

1441

R31

ICD-10 Finland

Unspecified haematuria

1.6

17.9

430

2760

A10BK03

ATC

empagliflozin; oral

1.6

17.8

435

2801

M05BA04

ATC

alendronic acid; oral

1.6

17.8

418

2666

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.0

17.8

252

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

17.8

1064

8158

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

3.5

17.8

172

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.4

17.8

127

547

EHB00

NOMESCO Finland

Excision of lesion of palate

7.2

17.8

E000002, ,

ATC

1.5

17.8

565

3861

V03AE02

ATC

sevelamer; oral

4.8

17.7

I50.0

ICD-10 Finland

Congestive heart failure

1.7

17.7

299

1749

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.9

17.7

285

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

4.5

17.7

SCA02

NOMESCO Finland

Preventive oral health care

1.5

17.7

537

3633

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

17.7

258

1447

N05AB03

ATC

perphenazine; systemic, rectal

2.0

17.6

186

936

H02AB02

ATC

dexamethasone; systemic

1.5

17.6

559

3817

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

17.6

265

1499

SPF03

NOMESCO Finland

Impression for dental prosthesis repair, demanding

3.6

17.6

159

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

17.6

125

537

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.7

17.6

364

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.1

17.6

228

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

17.6

464

3043

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

17.6

367

2275

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.8

17.6

273

1560

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

17.6

1953

16349

R63.4

ICD-10 Finland

Abnormal weight loss

2.0

17.5

195

1000

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.5

17.5

108

435

JAH01

NOMESCO Finland

Laparoscopy

1.8

17.5

243

1341

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.4

17.5

123

526

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

17.5

348

2130

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.7

17.5

146

F45.0

ICD-10 Finland

Somatization disorder

4.5

17.5

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.1

17.5

170

831

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.6

17.4

100

389

N05AX08

ATC

risperidone; systemic

1.6

17.4

390

2461

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.8

17.4

286

1662

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.2

17.4

139

629

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.5

17.3

109

444

M54.2

ICD-10 Finland

Cervicalgia

1.6

17.3

412

2639

D06AX01

ATC

fusidic acid; topical

1.6

17.3

474

3137

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.1

17.2

163

788

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.9

17.2

284

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.7

17.2

351

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.4

17.2

116

487

J01DC02

ATC

cefuroxime; systemic

1.7

17.2

290

1696

N06AA04

ATC

clomipramine; systemic

2.6

17.2

380

E000003, ,

ATC

1.9

17.2

225

1219

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.0

17.2

189

966

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

17.2

161

776

A10BH05

ATC

linagliptin; oral

1.9

17.2

225

1220

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

17.1

103

410

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

3.7

17.1

148

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.8

17.1

307

N77.1*A60.0

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection

4.0

17.1

121

U71

ICPC

Cystitis/urinary infection other

1.6

17.1

365

2274

M01AH02

ATC

rofecoxib; oral

1.5

17.1

603

4209

H57.1

ICD-10 Finland

Ocular pain

1.9

17.0

206

1088

E83.50

ICD-10 Finland

Hypercalcemia

2.9

17.0

270

SDA03

NOMESCO Finland

Periodontal treatment

1.3

17.0

2104

17834

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.2

17.0

143

661

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

17.0

2101

17808

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

5.5

16.9

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

3.8

16.9

131

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

16.9

537

3668

WX402

NOMESCO Finland

General anaesthesia

1.4

16.9

1063

8211

R01AD01

ATC

beclometasone; nasal

1.4

16.9

784

5761

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.1

16.9

157

755

J32.4

ICD-10 Finland

Chronic pansinusitis

2.8

16.8

310

UJH02

NOMESCO Finland

Anoscopy

1.9

16.8

209

1114

B02AA02

ATC

tranexamic acid; systemic

1.4

16.8

782

5747

N06AB05

ATC

paroxetine; oral

1.7

16.7

309

1854

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.1

16.7

155

744

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.8

16.7

300

S80.0

ICD-10 Finland

Contusion of knee

1.6

16.7

378

2391

1120B

ICD-9 Finland

Candidiasis, Of mouth[CANDIDIASIS REGIONIS GASTROINTESTITIALIS]

+∞

16.7

K08.3

ICD-10 Finland

Retained dental root

1.6

16.7

354

2204

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.7

16.6

346

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.7

16.6

335

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.7

16.6

341

R5110, ,

SPAT

1.7

16.6

320

1944

K10.26

ICD-10 Finland

Periostitis of jaw (acute)(chronic)(suppurative)

90.3

16.6

D05BB02

ATC

acitretin; oral

2.4

16.5

114

484

D01AE16

ATC

amorolfine; topical

1.5

16.5

550

3793

S06.0

ICD-10 Finland

Concussion

1.5

16.5

526

3595

N17

ICPC

Vertigo/dizziness

1.5

16.5

611

4305

S10

ICPC

Boil/carbuncle

1.7

16.5

287

1695

D01AE15

ATC

terbinafine; topical

1.7

16.4

318

1932

A04AA02

ATC

granisetron; systemic, transdermal

1.7

16.4

309

1863

C03.0

ICD-10 Finland

Malignant neoplasm: Upper gum

17.9

16.4

D06BB10

ATC

imiquimod; topical

1.8

16.4

262

1509

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.3

16.4

124

548

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.8

16.4

134

R4180

NOMESCO Finland

Podiatric therapy

3.0

16.4

238

SPC10

NOMESCO Finland

Standard dental crown

2.6

16.4

343

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.2

16.4

133

606

J43.9

ICD-10 Finland

Emphysema, unspecified

2.8

16.4

276

F61.0

ICD-10 Finland

Mixed personality disorders

2.6

16.3

384

B35.1

ICD-10 Finland

Tinea unguium

1.7

16.3

279

1639

R81

ICPC

Pneumonia

2.0

16.2

176

895

K65.0

ICD-10 Finland

Acute peritonitis

3.2

16.2

193

3AC01, ,

NOMESCO Finland

3.3

16.2

188

R06.4

ICD-10 Finland

Hyperventilation

2.6

16.2

374

SPE00

NOMESCO Finland

Partial denture with metal framework

2.6

16.2

345

WX290

NOMESCO Finland

Other blockage of nerve

1.3

16.2

2469

21420

M01AX17

ATC

nimesulide; oral

1.3

16.1

1142

8973

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.9

16.1

203

1087

Z72.0

ICD-10 Finland

Tobacco use

2.2

16.1

137

636

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.0

16.1

178

912

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.2

16.1

136

630

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.0

16.1

225

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

16.0

196

1039

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

16.0

315

1922

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.5

16.0

102

418

SPA50

NOMESCO Finland

Determination of bite and dental arch location

2.8

16.0

285

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

5.1

16.0

M01AH01

ATC

celecoxib; oral

1.4

15.9

863

6503

Z00.0

ICD-10 Finland

General medical examination

1.4

15.9

956

7325

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.7

15.9

310

1888

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.4

15.9

107

450

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.4

15.9

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

15.8

2211

18969

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

6.4

15.8

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.5

15.8

373

R04.0

ICD-10 Finland

Epistaxis

1.6

15.7

336

2095

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

15.7

261

1521

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

15.7

664

4794

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.1

15.7

157

776

C08CA05

ATC

nifedipine; systemic

1.7

15.7

281

1673

R12

ICD-10 Finland

Heartburn

1.6

15.6

403

2631

A97

ICPC

No disease

1.4

15.5

897

6827

A10BJ02

ATC

liraglutide; parenteral

2.1

15.5

141

672

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.6

15.5

347

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

15.5

229

1290

D02

ICPC

Abdominal pain epigastric

1.7

15.5

318

1963

R55

ICD-10 Finland

Syncope and collapse

1.5

15.5

504

3459

ZX121

NOMESCO Finland

Central venous catheter

4.8

15.4

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

5.4

15.4

D05AX52

ATC

calcipotriol, combinations; topical

1.8

15.4

252

1463

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.1

15.4

149

728

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.8

15.4

280

L14

ICPC

Leg/thigh symptom/complaint

1.6

15.3

390

2536

S01

ICPC

Pain/tenderness of skin

1.8

15.3

235

1338

318

Kela drug reimbursment

Teriparatide

4.1

15.3

100

S21

ICPC

Skin texture symptom/complaint

1.4

15.3

691

5047

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.0

15.3

216

UDC00

NOMESCO Finland

Ear microscopy

1.6

15.3

364

2332

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.1

15.2

138

657

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

15.2

1431

11682

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.7

15.2

285

1719

L60.0

ICD-10 Finland

Ingrowing nail

1.8

15.2

233

1328

F10.24

ICD-10 Finland

Alcohol depence active use

2.8

15.2

271

Z93.2

ICD-10 Finland

Ileostomy status

4.7

15.1

NGQ20

NOMESCO Finland

Amputation of lower leg

4.6

15.1

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.5

15.1

363

A05AA02

ATC

ursodeoxycholic acid; oral

2.4

15.1

100

417

B01AB10

ATC

tinzaparin; parenteral

1.5

15.1

480

3277

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.5

15.1

399

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.8

15.1

210

1161

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.1

15.1

137

653

D09

ICPC

Nausea

1.8

15.1

243

1404

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

15.1

147

720

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.4

15.0

106

455

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

15.0

218

1221

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

15.0

932

7171

SPAT1251

SPAT

Organisation of medication

2.0

15.0

166

851

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

15.0

483

3307

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

15.0

780

5836

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

15.0

202

1106

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

3.1

15.0

208

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.9

15.0

240

J01AA04

ATC

lymecycline; systemic

1.4

14.9

669

4878

M01AX01

ATC

nabumetone; oral

1.8

14.9

205

1129

UJC02

NOMESCO Finland

Rigid oesophagoscopy

3.5

14.9

148

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.6

14.9

313

R39.1

ICD-10 Finland

Other difficulties with micturition

2.1

14.9

135

643

J01AA07

ATC

tetracycline; systemic

1.4

14.9

763

5694

J96.1

ICD-10 Finland

Chronic respiratory failure

2.4

14.8

100

421

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.3

14.8

106

458

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

14.8

281

1700

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.8

14.8

258

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

3.4

14.8

149

JFB00

NOMESCO Finland

Partial resection of small intestine

2.6

14.8

309

B00.11

ICD-10 Finland

Herpes simplex labialis

2.4

14.7

100

422

Z72.2

ICD-10 Finland

Drug use

4.0

14.7

103

E83.51

ICD-10 Finland

Hypocalcemia

3.9

14.7

112

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.5

14.7

140

S06

ICPC

Rash localized

1.7

14.6

271

1628

N94.1

ICD-10 Finland

Dyspareunia

2.5

14.6

357

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

5.3

14.6

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

14.6

263

1568

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.9

14.6

227

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

14.6

183

980

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.7

14.5

247

1449

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.1

14.5

201

A07DA03

ATC

loperamide; oral

2.0

14.5

159

812

R29

ICPC

Respiratory symptom/complaint other

1.6

14.5

337

2146

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.5

14.5

353

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

14.5

433

2919

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

14.4

2372

20664

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.0

14.4

202

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.6

14.4

313

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.5

14.4

378

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

3.1

14.4

192

D01AC03

ATC

econazole; topical

1.7

14.4

278

1690

K13.03

ICD-10 Finland

Keilit UNS

5.2

14.4

Z00.8

ICD-10 Finland

Other general examinations

1.6

14.3

377

2471

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

3.3

14.3

162

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.5

14.3

373

G04BD12

ATC

mirabegron; oral

1.5

14.3

540

3815

Z53.0

ICD-10 Finland

Procedure not carried out because of contraindication

6.0

14.3

L84

ICD-10 Finland

Corns and callosities

1.9

14.3

166

866

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.1

14.3

198

T74.1

ICD-10 Finland

Physical abuse

2.3

14.3

102

441

A10AE06

ATC

insulin degludec; parenteral

2.0

14.2

161

832

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

14.2

272

1648

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.4

14.2

386

S04

ICPC

Lump/swelling localized

1.5

14.2

519

3643

K29.8

ICD-10 Finland

Duodenitis

3.4

14.2

148

SPAT1058

SPAT

PEF monitoring instruction

1.5

14.2

402

2678

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.9

14.2

170

896

Z94.2

ICD-10 Finland

Lung transplant status

10.4

14.2

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

6.2

14.2

WX199

NOMESCO Finland

Other local analgesia

2.0

14.2

157

806

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

14.1

181

975

WX722

NOMESCO Finland

PEEP

1.8

14.1

207

1163

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.7

14.1

270

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.7

14.1

120

ZXC10

NOMESCO Finland

Use of laser

2.2

14.1

114

519

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.9

14.1

177

948

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

14.1

409

2740

P03

ICPC

Feeling depressed

1.5

14.1

504

3525

EAA10

NOMESCO Finland

Excision of lesion of lip

2.7

14.0

271

Z96.5

ICD-10 Finland

Presence of tooth-root and mandibular implants

4.9

14.0

L13

ICPC

Hip symptom/complaint

1.3

14.0

883

6805

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

14.0

371

2435

K12.2

ICD-10 Finland

Cellulitis and abscess of mouth

2.9

14.0

227

R04

ICPC

Breathing problem other

1.9

14.0

180

971

A10AD05

ATC

insulin aspart; parenteral

2.5

14.0

341

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.2

14.0

122

573

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

14.0

187

1022

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.7

13.9

272

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

13.9

369

2422

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

3.4

13.9

145

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

13.9

328

2095

JN6AD

NOMESCO Finland

CT of torso and neck

2.5

13.9

330

SPA47

NOMESCO Finland

Precision impression for denture

2.1

13.9

122

574

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.2

13.9

116

535

B02.9

ICD-10 Finland

Zoster without complication

1.6

13.9

311

1962

-, ,

ICD-10 Finland

2.2

13.9

110

497

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.7

13.9

244

1446

WVA20, ,

SPAT

2.1

13.9

130

628

SFA30

NOMESCO Finland

Three-surface restoration

1.2

13.8

2100

18111

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

13.8

297

1855

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.4

13.8

141

M81.4

ICD-10 Finland

Drug-induced osteoporosis

4.3

13.8

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.3

13.8

156

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

13.8

288

1787

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.5

13.7

356

F29

ICPC

Eye symptom/complaint other

1.5

13.7

466

3224

SFA00

NOMESCO Finland

Small restoration

1.4

13.7

682

5061

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

2.9

13.7

219

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.6

13.7

293

1828

F32.1

ICD-10 Finland

Moderate depressive episode

1.6

13.7

304

1915

ZX120, ,

SPAT

3.1

13.7

177

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

13.7

462

3194

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.0

13.7

141

706

SPAT1285

SPAT

Provision of consultation response

1.7

13.6

256

1544

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.2

13.6

167

WZC00, ,

SPAT

1.5

13.6

490

3429

N07BA03

ATC

varenicline; oral

1.7

13.6

227

1325

R15

ICD-10 Finland

Faecal incontinence

2.0

13.6

145

734

A07EA02

ATC

hydrocortisone; rectal

2.2

13.6

112

514

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

2.9

13.6

220

N05AD01

ATC

haloperidol; systemic

2.0

13.6

137

680

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.0

13.6

153

790

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

13.6

459

3173

EMAK, ,

NOMESCO Finland

1.8

13.6

192

1068

V03AA01, ,

ATC

2.7

13.6

259

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.1

13.5

126

607

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

13.5

138

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.1

13.5

173

H3601, E103,

ICD-10 Finland

3.3

13.5

153

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

13.5

122

582

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

13.4

2864

25581

A02BX02

ATC

sucralfate; oral

1.8

13.4

182

999

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

10.0

13.4

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

3.7

13.4

115

Z50.1

ICD-10 Finland

Other physical therapy

1.7

13.4

251

1513

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.0

13.4

141

711

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

3.9

13.4

G04BD08

ATC

solifenacin; oral

1.6

13.4

301

1902

N04BC05

ATC

pramipexole; oral

1.6

13.4

359

2364

M86.6

ICD-10 Finland

Other chronic osteomyelitis

5.6

13.3

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

5.0

13.3

Z94.4

ICD-10 Finland

Liver transplant status

5.0

13.3

JF1BD

NOMESCO Finland

Very extensive small bowel CT

4.0

13.3

H05AA02

ATC

teriparatide; parenteral

4.0

13.3

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.1

13.3

127

618

A99

ICPC

Disease/condition unspecnature/site

1.5

13.3

448

3095

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

13.3

141

713

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

3.1

13.3

175

K05.19

ICD-10 Finland

Gingivitis (chronic) ulcerative

2.0

13.3

138

693

R49.08

ICD-10 Finland

Other specified dysphonia

2.1

13.2

116

546

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.8

13.2

200

1135

R51.81

ICD-10 Finland

Facial pain NOS

2.1

13.2

131

646

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

13.2

288

1805

A10BJ06

ATC

semaglutide; parenteral

1.7

13.2

220

1284

GDG10

NOMESCO Finland

Bilateral transplantation of lung

13.8

13.2

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.7

13.2

263

B37.05

ICD-10 Finland

Candidal granuloma of mouth

40.1

13.1

K56.0

ICD-10 Finland

Paralytic ileus

3.2

13.1

156

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.7

13.1

224

1318

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.1

13.1

125

609

M01AC06

ATC

meloxicam; systemic, rectal

1.2

13.1

1799

15326

Z49.2

ICD-10 Finland

Other dialysis

3.5

13.0

122

L01AA01

ATC

cyclophosphamide; systemic

4.8

13.0

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.4

13.0

359

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.4

13.0

353

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

13.0

432

2975

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

13.0

604

4429

L88

ICPC

Rheumatoid/seropositive arthritis

1.8

13.0

196

1112

R06AE09

ATC

levocetirizine; oral

1.4

13.0

730

5524

A08

ICPC

Swelling

1.7

13.0

238

1427

S22.3

ICD-10 Finland

Fracture of rib

1.6

13.0

312

2003

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.2

13.0

107

492

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.2

13.0

157

ECA30

NOMESCO Finland

Excision of lesion of gingiva

2.9

13.0

215

J01DA06

ATC

[U] cefuroxime

1.4

12.9

693

5204

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.1

12.9

178

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.9

12.9

156

826

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.5

12.9

319

F31

ICD-10 Finland

Bipolar affective disorder

2.7

12.9

255

A29

ICPC

General symptom/complaint other

1.4

12.9

586

4283

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.4

12.8

138

R2110

NOMESCO Finland

Giving the first information

1.6

12.8

344

2265

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

4.7

12.8

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.8

12.8

222

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

2.7

12.8

250

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

2.9

12.8

206

NF1DA

NOMESCO Finland

X-ray of hips

2.2

12.7

106

489

P17

ICPC

Tobacco abuse

2.5

12.7

297

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.0

12.7

130

649

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

12.7

664

4965

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

3.3

12.7

144

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.1

12.7

111

523

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

2.9

12.6

207

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

12.6

510

3647

160

Kela drug reimbursment

exenatide

2.3

12.6

414

S22

ICPC

Nail symptom/complaint

1.6

12.6

300

1922

N19

ICD-10 Finland

Unspecified kidney failure

1.9

12.6

147

769

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.6

12.6

309

1994

C06.0

ICD-10 Finland

Malignant neoplasm: Cheek mucosa

12.3

12.6

F17.22

ICD-10 Finland

Addiction-related addiction currently uses controlled substitution treatment

6.0

12.6

H02AA02

ATC

fludrocortisone; oral

3.2

12.6

150

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.1

12.5

L50.9

ICD-10 Finland

Urticaria, unspecified

1.8

12.5

190

1080

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.0

12.5

138

708

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

12.5

333

2190

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.5

12.5

318

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.9

12.5

149

786

EJ1S1

NOMESCO Finland

Photography of tongue

6.2

12.5

107

Kela drug reimbursment

Pernicious anaemia

2.3

12.4

398

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.0

12.4

182

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

12.4

755

5780

E31.00

ICD-10 Finland

APECED syndrome

130.3

12.4

R00.2

ICD-10 Finland

Palpitations

1.5

12.4

392

2672

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

12.4

324

2120

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.3

12.4

141

R4130

NOMESCO Finland

Speech therapy

2.1

12.4

121

594

WX730

NOMESCO Finland

Conventional respirator

2.5

12.4

289

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

12.4

369

2485

J01XC01

ATC

fusidic acid; systemic

2.6

12.4

260

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.9

12.4

156

837

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.8

12.4

215

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.6

12.4

266

J01

ICD-10 Finland

Acute sinusitis

1.6

12.3

282

1789

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.3

12.3

406

EKB00

NOMESCO Finland

Excision of tumour or other lesion of cheek

3.8

12.3

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.0

12.3

124

616

L85.3

ICD-10 Finland

Xerosis cutis

2.8

12.3

216

SPF11

NOMESCO Finland

Fitting of dental prosthesis

3.2

12.3

147

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

5.4

12.3

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.9

12.3

141

734

R01AD05

ATC

budesonide; nasal

1.5

12.3

369

2491

K14.09

ICD-10 Finland

Glossit UNS

5.8

12.2

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.5

12.2

387

2640

NH1AD

NOMESCO Finland

Ankle and foot CT

2.1

12.2

115

557

AN1

Coronary angiography

1.5

12.2

436

3046

A06AH03

ATC

naloxegol; oral

2.6

12.2

274

R30.9

ICD-10 Finland

Painful micturition, unspecified

3.0

12.2

179

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.0

12.2

179

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

12.2

215

1277

A10AA01, ,

ATC

2.0

12.2

124

619

WX610

NOMESCO Finland

Patient controlled analgesia

3.2

12.1

148

L15

ICPC

Knee symptom/complaint

1.3

12.1

1151

9370

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.9

12.1

139

723

M05BA07

ATC

risedronic acid; oral

1.9

12.1

142

744

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

12.1

357

2399

J01XE01

ATC

nitrofurantoin; oral

2.2

12.1

422

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.1

12.1

117

573

R06.5

ICD-10 Finland

Mouth breathing

1.5

12.1

396

2721

D99

ICPC

Disease digestive system other

2.8

12.1

207

N90.8

ICD-10 Finland

Other specified noninflammatory disorders of vulva and perineum

2.7

12.1

235

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

12.1

380

2590

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.5

12.1

311

EB1AD

NOMESCO Finland

Cone beam CT of teeth and jaws (one quarter)

3.9

12.1

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.5

12.0

119

SPD01

NOMESCO Finland

Mucosa-supported complete denture

2.9

12.0

191

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.4

12.0

336

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

12.0

1376

11460

A10BJ05

ATC

dulaglutide; parenteral

2.2

12.0

430

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

3.0

12.0

170

R4120

NOMESCO Finland

Occupational therapy

1.6

12.0

309

2018

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

12.0

169

941

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.1

11.9

112

542

A10BX07

ATC

[U] liraglutide

2.7

11.9

242

M01AH05

ATC

etoricoxib; oral

1.2

11.9

3221

29308

105

Kela drug reimbursment

Adrenal cortical hypofunction

5.7

11.9

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.3

11.9

374

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

11.9

110

529

QDB10, ,

SPAT

2.4

11.9

337

D02AX

ATC

Other emollients and protectives

1.9

11.9

157

855

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

11.9

138

721

D83

ICPC

Mouth/tongue/lip disease

3.4

11.9

125

K60.0

ICD-10 Finland

Acute anal fissure

2.7

11.9

237

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.0

11.9

171

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

2.1

11.9

103

484

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.7

11.9

206

1218

D95

ICPC

Anal fissure/perianal abscess

3.0

11.8

166

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.2

11.8

426

OAB50, ,

SPAT

1.6

11.8

242

1494

-1, ,

NOMESCO Finland

1.2

11.8

1677

14299

L08.0

ICD-10 Finland

Pyoderma

2.9

11.8

193

KH1AD

NOMESCO Finland

CT of urinary organs

1.9

11.8

153

829

K07

ICPC

Swollen ankles/oedema

1.7

11.8

205

1212

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

11.8

692

5269

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.0

11.8

126

640

JJC00

NOMESCO Finland

Allogenic transplantation of liver

5.8

11.8

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

11.7

856

6728

O04.6

ICD-10 Finland

Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage

2.8

11.7

205

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.1

11.7

110

533

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.5

11.7

298

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.8

11.7

200

A10AA02, ,

ATC

1.9

11.6

146

783

SPA60

NOMESCO Finland

Fitting of intermediary dental prosthesis structures, 1 to 3 units

2.4

11.6

347

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.2

11.6

455

SPE90

NOMESCO Finland

Other partial denture

2.2

11.6

455

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

4.7

11.6

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.7

11.6

217

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

2.0

11.6

129

664

T82

ICPC

Obesity

1.7

11.6

200

1180

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.8

11.6

195

SPAT1097

SPAT

Recording of ECG

1.4

11.6

653

4940

H29

ICPC

Ear symptom/complaint other

1.4

11.6

536

3927

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

11.6

179

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

11.6

401

2787

K13.6

ICD-10 Finland

Irritative hyperplasia of oral mucosa

2.8

11.5

201

Z2445

NOMESCO Finland

Psychologist

1.7

11.5

187

1085

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.0

11.5

115

570

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.1

11.5

153

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

11.5

1792

15424

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

2.6

11.5

241

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

11.5

203

1206

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

11.5

584

4346

B05DA

ATC

Isotonic solutions

3.4

11.5

118

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.2

11.5

138

1122A

ICD-9 Finland

Candidiasis, Of other urogenital sites[CANDIDIASIS BALANITIS]

+∞

11.5

J17.2*B37.1

ICD-10 Finland

Pneumonia in candidiasis

+∞

11.5

D10

ICPC

Vomiting

1.6

11.4

295

1926

EEB00

NOMESCO Finland

Partial excision of maxilla

13.6

11.4

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.3

11.4

394

EB1AA, ,

SPAT

1.5

11.4

321

2136

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

4.4

11.4

SPC40

NOMESCO Finland

Preparation of first or second intermediate attachment tooth for bridge

3.6

11.4

104

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.5

11.4

283

M54.3

ICD-10 Finland

Sciatica

1.6

11.4

287

1863

K10.3

ICD-10 Finland

Alveolitis of jaws

1.6

11.4

236

1462

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.8

11.4

161

897

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

11.4

197

1164

205

Kela drug reimbursment

Chronic hypertension

1.3

11.4

1121

9163

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.5

11.4

354

2408

N30.2

ICD-10 Finland

Other chronic cystitis

2.8

11.3

192

A10BK01

ATC

dapagliflozin; oral

1.6

11.3

293

1914

D05AX02

ATC

calcipotriol; topical

1.8

11.3

162

906

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

11.3

2002

17452

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

15.0

11.3

M10.9

ICD-10 Finland

Gout, unspecified

1.6

11.3

260

1654

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

11.3

1017

8220

J01FA01

ATC

erythromycin; systemic

1.3

11.2

690

5288

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.9

11.2

129

672

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

11.2

292

1910

JN4CD

NOMESCO Finland

Very extensive body CT

1.8

11.2

158

879

N05AA01

ATC

chlorpromazine; systemic, rectal

2.6

11.2

244

L43

ICD-10 Finland

Lichen planus

2.6

11.2

256

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.3

11.2

125

M01CB01

ATC

sodium aurothiomalate; parenteral

2.4

11.2

292

H02BX01

ATC

methylprednisolone, combinations; systemic

1.7

11.2

223

1369

R09

ICPC

Sinus symptom/complaint

1.4

11.2

421

2973

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.3

11.2

360

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

11.2

228

1408

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.8

11.1

161

903

N06AX22

ATC

agomelatine; oral

2.0

11.1

116

584

R52.0

ICD-10 Finland

Acute pain

1.8

11.1

172

984

WX004

NOMESCO Finland

Patient-controlled sedation

3.5

11.1

106

K56.7

ICD-10 Finland

Ileus, unspecified

2.3

11.1

342

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.8

11.1

149

817

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

11.1

128

668

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.5

11.1

287

SPAT1210

SPAT

Application of cast or individual aid

1.7

11.1

201

1203

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.7

11.1

200

1196

N05BA02

ATC

chlordiazepoxide; systemic

2.1

11.1

105

511

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

11.1

135

718

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

3.2

11.1

131

A05

ICPC

Feeling ill

1.6

11.1

285

1861

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.2

11.1

432

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

4.2

11.0

L03AA13

ATC

pegfilgrastim; parenteral

1.7

11.0

206

1243

C09AA02

ATC

enalapril; systemic

1.3

11.0

807

6343

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

11.0

439

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026389) Candida sp identified in Specimen by Organism specific culture

649

709

10.14

307.65

2.1

1.2

—

(3000494) Fungus identified in Specimen by Culture

1527

5555

3.34

307.65

2.2

1.4

—

(3023368) Bacteria identified in Blood by Culture

2245

12285

2.32

199.09

8.2

4.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

1317

5675

2.69

196.29

2.5

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

3505

23275

2.21

189.98

10.7

6.2

—

(3013115) Eosinophils [#/volume] in Blood

3736

25707

2.19

181.52

10.2

5.9

0.19

e9/l

0.19

3347

22607

(3042936) Bacteria identified in Isolate by Culture

1422

6622

2.50

178.63

2.8

1.9

—

(3001604) Monocytes [#/volume] in Blood

3614

24786

2.14

173.79

9.6

5.7

0.59

0.57

e9/l

3.77

3240

21454

(3006315) Basophils [#/volume] in Blood

3620

24844

2.14

173.76

9.6

5.7

0.04

e9/l

1.02

3242

21479

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1521

7448

2.39

169.96

2.6

1.8

—

(3019198) Lymphocytes [#/volume] in Blood

3681

25547

2.13

169.91

9.7

5.7

1.87

1.94

e9/l

1.29

3346

22665

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

884

3392

2.88

162.30

2.4

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3612

25164

2.09

161.39

10.0

5.9

10.54

11.09

umol/l

1.71

3411

23811

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3236

21688

2.06

160.34

11.3

5.6

1.21

mmol/l

7.12

2942

19729

(3013650) Neutrophils [#/volume] in Blood by Automated count

3968

28760

2.11

157.61

14.9

8.8

4.32

4.05

e9/l

10.60

3572

25098

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1500

7523

2.32

157.01

6.8

3.2

0.81

0.82

mmol/l

2.58

1413

7020

(3019069) Monocytes/100 leukocytes in Blood

3386

23437

2.02

149.04

10.6

6.2

8.40

8.46

0.51

3187

21940

(3022096) Basophils/100 leukocytes in Blood

3286

22570

2.00

147.11

10.0

5.9

0.65

0.68

2.33

3070

21035

(3006504) Eosinophils/100 leukocytes in Blood

3365

23311

2.00

146.93

10.0

5.9

2.67

2.83

3.74

3160

21777

(3002030) Lymphocytes/100 leukocytes in Blood

3449

24130

2.00

146.03

10.3

5.9

26.66

28.37

15.74

3247

22643

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3422

23968

1.99

143.31

12.6

6.3

1.21

1.22

mmol/l

5.96

2909

20285

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2443

15225

2.02

143.28

3.8

2.5

54.82

64.45

u/l

1.13

2250

14036

(3018010) Neutrophils/100 leukocytes in Blood

3402

23788

1.99

143.07

9.8

5.8

58.63

56.97

12.51

3202

22296

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1229

5958

2.33

137.10

10.1

5.6

1.05

1.04

mmol/l

0.91

1152

5535

(3024561) Albumin [Mass/volume] in Serum or Plasma

3021

20707

1.92

130.02

8.3

4.6

34.39

35.75

g/l

28.77

2825

19205

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

393

1049

3.94

128.75

2.2

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

355

890

4.18

126.71

11.4

5.1

1139.27

630.40

iu/ml

0.43

121

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2047

12394

1.99

126.67

3.0

2.2

3.21

2.89

mg/l

5.60

1762

10596

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

513

1674

3.26

123.70

2.8

1.9

1.78

2.10

ug/l

0.34

460

1482

(3031040) Bacteria [#/volume] in Urine by Automated count

4306

33560

1.99

122.00

7.3

4.3

52.60

1512.35

e6/l

5.46

424

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1075

5168

2.31

120.85

5.5

4.1

243.99

242.99

u/l

0.08

1009

4878

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

306

720

4.42

118.61

2.2

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

306

720

4.42

118.61

2.2

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

886

3942

2.46

118.51

13.2

7.2

9.81

9.38

mmol/l

0.96

840

3772

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

376

1032

3.82

118.24

2.3

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

3052

21453

1.86

116.86

17.6

13.7

1.19

1.23

inr

1.55

785

6379

(3013826) Glucose [Moles/volume] in Serum or Plasma

3784

28517

1.88

115.25

8.8

4.4

6.88

6.60

mmol/l

9.46

3579

26425

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1041

5056

2.28

113.63

2.4

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4397

34878

1.96

113.44

6.7

4.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

440

1380

3.36

112.92

3.4

2.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

835

3698

2.46

112.45

3.5

2.6

9.88

10.54

g/l

3.59

768

3375

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2605

17582

1.85

112.18

5.2

3.4

113.10

75.11

ng/l

0.20

1839

11227

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1959

12075

1.92

112.11

3.3

2.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1533

8708

2.02

111.21

1.9

1.7

1210.31

1163.85

nmol/l

1.12

1162

6590

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1036

5064

2.26

111.16

2.5

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4655

37769

2.02

110.91

13.3

7.2

81.74

77.21

u/l

7.16

4424

35563

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3191

23031

1.82

109.29

3.8

2.9

129.51

108.38

ug/l

2.82

2961

21405

(3044640) Blood type and Crossmatch panel - Blood

2404

15959

1.84

108.08

3.5

2.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

969

4676

2.28

106.90

2.7

2.1

348.08

376.01

nmol/l

3.70

887

4283

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2822

19722

1.81

106.68

2.3

1.9

96.24

96.67

pmol/l

0.17

1568

10090

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

658

2673

2.64

105.90

5.8

3.7

1.86

1.76

mmol/l

0.30

503

1964

(3027945) Reticulocytes/100 erythrocytes in Blood

1018

5033

2.23

105.81

3.2

2.5

1.95

1.77

3.61

894

4452

(40768797) Stomach Pathology biopsy report

1260

6776

2.09

105.52

1.3

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1357

7503

2.04

105.36

3.2

2.4

12.06

13.29

umol/l

7.49

1265

6997

(3009343) pH of Capillary blood

670

2774

2.59

103.64

5.9

3.7

7.42

0.49

333

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

923

4418

2.29

103.57

2.9

2.2

0.21

g/l

2.21

859

4131

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

674

2808

2.58

102.89

5.9

3.7

5.21

5.14

kpa

0.96

641

2669

(3016502) Oxygen saturation in Arterial blood

923

4444

2.27

102.02

11.8

7.6

95.48

95.81

0.90

885

4268

(3028026) IgM [Mass/volume] in Serum or Plasma

682

2869

2.55

101.99

2.1

1.8

1.23

1.38

g/l

1.42

614

2621

(3019060) Gas panel - Arterial blood

675

2845

2.55

100.48

7.1

4.8

—

(3026008) Bacteria identified in Urine by Culture

2325

15534

1.81

100.34

4.4

3.0

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1004

5039

2.19

100.07

11.3

7.1

11.77

12.63

kpa

6.03

959

4797

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1004

5040

2.19

100.02

11.3

7.1

5.03

5.07

kpa

0.70

958

4802

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

290

746

4.03

99.70

2.0

1.3

—

(3003396) Base excess in Arterial blood by calculation

1000

5023

2.19

99.42

11.3

7.1

1.23

1.05

mmol/l

0.68

819

3949

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

243

548

4.58

99.25

1.9

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1736

10625

1.89

99.19

2.2

1.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1249

6891

2.02

96.54

3.3

2.4

2.31

2.36

g/l

2.19

1158

6373

(3023520) Reticulocytes [#/volume] in Blood

802

3729

2.33

95.87

3.0

2.5

73.33

70.21

e9/l

1.23

613

2777

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

262

644

4.21

95.76

1.8

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2913

20989

1.75

95.42

2.9

2.2

77.97

77.05

nmol/l

0.92

2617

18930

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1778

11087

1.86

95.05

2.4

1.7

1.08

1.16

mg/l

0.69

1337

8348

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2159

14284

1.80

94.99

2.8

2.1

158.70

199.43

u/l

1.88

2041

13362

(3021960) Folate [Moles/volume] in Serum or Plasma

1761

10971

1.85

94.28

1.7

1.5

20.43

20.68

nmol/l

0.28

1514

9401

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

272

696

4.05

94.15

4.8

2.6

372.24

1536.59

u/ml

1.00

(3013707) Erythrocyte sedimentation rate by Westergren method

4515

37043

1.87

93.30

6.2

4.0

14.42

11.76

mm/h

22.33

4214

34321

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1173

6414

2.03

92.54

3.4

2.5

21.21

22.84

3.23

992

5483

(3023419) Bacteria identified in Sputum by Culture

254

630

4.16

91.70

3.7

2.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1662

10249

1.86

91.43

1.7

1.4

2.42

2.34

g/l

0.64

1059

6210

(3012544) pH of Venous blood

872

4280

2.21

91.26

7.9

3.6

7.37

7.39

0.55

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1941

12561

1.80

91.14

3.8

2.9

1397.08

1319.36

ng/l

0.34

1645

10666

(3002032) Base excess in Venous blood by calculation

849

4129

2.23

90.86

8.0

3.7

1.81

1.94

mmol/l

0.46

734

3484

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

281

757

3.84

90.49

2.3

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

846

4147

2.21

88.65

8.0

3.7

5.80

5.83

kpa

0.29

817

4021

(3037522) Nuclear Ab [Titer] in Serum

1231

6957

1.97

87.90

1.5

1.4

502.96

554.12

titre

0.46

277

1469

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3188

23923

1.71

87.05

3.7

2.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

834

4130

2.18

84.96

12.6

8.0

116.95

121.29

g/l

7.66

813

4010

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

214

501

4.39

83.30

2.1

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

214

501

4.39

83.30

2.1

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

380

1316

3.01

82.09

1.6

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2362

16537

1.70

81.86

4.3

3.3

2.34

2.35

mmol/l

8.03

2051

14554

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

157

290

5.53

80.82

2.1

1.5

—

(3019225) pH of Specimen

915

4820

2.06

78.87

5.1

4.1

—

(3011412) CD3 cells [#/volume] in Blood

199

463

4.41

78.06

2.4

2.3

1.27

1.20

e9/l

0.42

176

412

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

203

484

4.31

77.16

2.0

1.5

—

(3000991) Gas panel - Venous blood

752

3729

2.16

75.83

14.9

8.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

494

2053

2.53

74.97

1.9

1.8

1.56

1.51

g/l

0.43

420

1762

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

222

578

3.95

74.94

1.9

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1087

6199

1.92

74.23

1.9

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

221

579

3.92

73.95

9.6

6.4

11.89

11.67

mg/l

0.27

203

536

(3015736) pH of Urine

2692

19875

1.64

73.63

5.1

3.3

6.19

5.90

3.86

169

1584

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

591

2696

2.32

72.90

1.8

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

596

2734

2.31

72.55

10.9

6.7

24.75

24.48

mmol/l

0.90

573

2590

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

400

1522

2.74

72.47

3.0

2.2

435.08

626.79

ug/l

0.54

374

1417

(3009445) Proteinase 3 Ab [Units/volume] in Serum

471

1951

2.53

71.89

1.7

1.6

19.73

14.61

u/ml

0.20

(3022313) Gas panel - Capillary blood

483

2026

2.50

71.79

6.2

3.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

186

442

4.31

70.99

2.0

1.5

—

(40768804) Tissue Pathology biopsy report

2765

20729

1.62

69.79

2.5

2.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

216

587

3.78

68.59

2.1

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

758

3927

2.06

67.68

11.9

6.7

1.39

1.34

mmol/l

0.62

740

3830

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

200

522

3.93

67.26

1.5

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

681

3405

2.13

66.77

6.7

3.1

4.67

4.62

kpa

0.20

653

3289

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1752

11829

1.68

66.32

1.4

1.3

2.23

1.58

u/ml

0.72

396

3162

(3048689) Calprotectin [Mass/mass] in Stool

1091

6474

1.84

64.92

2.7

2.2

139.00

121.97

ug/g

0.78

867

5099

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

428

1785

2.50

64.23

6.6

3.9

25.05

24.79

mmol/l

0.96

403

1654

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

147

318

4.71

63.14

2.4

0.22

e9/l

0.13

124

274

(4200892) Spirometry reversibility

671

3409

2.09

62.90

1.6

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1172

7174

1.79

62.67

3.0

2.1

29.62

29.67

0.10

1139

6944

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

160

374

4.37

62.38

2.0

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

160

374

4.37

62.38

2.0

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

160

374

4.37

62.38

2.0

1.4

—

(3018418) pH of Serum or Plasma

2013

14258

1.62

62.17

7.7

3.8

7.40

0.32

369

2709

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

569

2731

2.20

61.72

13.9

8.7

1.50

1.33

3.08

564

2713

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1141

6959

1.79

61.66

2.7

2.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1046

6226

1.82

61.27

2.6

2.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

111

193

5.84

60.93

31.0

26.6

129.90

108.90

ug/l

1.78

161

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2221

16164

1.59

60.93

5.0

3.1

36.12

34.74

u/l

0.12

2104

15335

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

148

332

4.54

60.79

2.4

560.85

515.43

e6/l

0.40

123

276

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

705

3700

2.03

60.37

3.1

2.3

7.36

6.78

ug/l

0.23

593

3218

(3018095) Leukocytes [#/volume] in Urine

2347

17346

1.58

60.02

5.9

3.6

134.10

100.47

e6/l

0.48

1737

11979

(3020891) Body temperature

409

1725

2.47

59.84

7.5

4.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

562

2717

2.18

59.79

14.3

8.8

0.71

0.68

0.87

557

2697

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

145

325

4.55

59.62

2.7

2.5

637.29

712.97

e6/l

0.82

140

312

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

692

3630

2.02

59.28

5.1

3.7

105.49

85.97

ng/l

2.04

586

3120

(3037692) Legionella sp identified in Specimen by Organism specific culture

137

6.80

58.83

1.7

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

149

345

4.40

58.81

1.9

2.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

381

1574

2.52

58.24

1.8

1.17

g/l

0.02

363

1488

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3987

33361

1.58

57.60

4.7

3.0

58.96

44.48

u/l

9.25

3730

31143

(3004119) Hemoglobin [Mass/volume] in Venous blood

550

2676

2.16

57.50

6.9

3.1

121.35

129.10

g/l

12.21

539

2605

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

127

264

4.89

57.22

3.2

2.6

36.55

43.22

3.20

146

(3005322) IgE [Units/volume] in Serum or Plasma

629

3245

2.05

56.29

1.5

1.3

248.00

191.24

u/ml

0.67

584

2991

(3026250) Tacrolimus [Mass/volume] in Blood

102

177

5.84

56.12

48.2

33.4

7.95

7.37

ug/l

0.80

162

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

368

1523

2.51

56.01

1.8

0.23

g/l

0.34

349

1437

(3027273) Bicarbonate [Moles/volume] in Venous blood

454

2066

2.29

55.87

5.4

3.2

25.34

25.30

mmol/l

0.06

441

2001

(3023183) Ammonium ion [Moles/volume] in Plasma

264

923

2.95

55.85

4.4

2.7

36.68

34.77

umol/l

0.48

240

846

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

988

5931

1.80

55.78

4.4

33.12

32.61

0.65

670

4071

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

976

5846

1.80

55.49

11.9

6.4

—

(3030467) Casts [#/volume] in Urine by Automated count

1878

13377

1.59

55.14

5.0

3.0

0.37

0.40

e6/l

0.21

1502

10104

(3020630) Protein [Mass/volume] in Serum or Plasma

689

3720

1.96

54.11

3.3

2.5

64.79

66.59

g/l

6.66

622

3395

(3026782) Osmolality of Urine

1435

9627

1.64

53.71

4.5

2.8

514.53

535.22

mosm/kgh2o

3.19

1266

8218

(3035350) Ketones [Presence] in Urine by Test strip

3096

24739

1.52

53.21

5.7

3.6

0.00

estimate

0.09

574

5012

(36304419) Bacteria [Presence] in Urine

1838

13130

1.58

52.81

5.0

3.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

433

1977

2.28

52.80

2.7

1.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1747

12342

1.59

52.62

3.9

2.5

3623.34

4432.69

umol/l

0.38

1517

10835

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4570

39815

1.61

52.44

5.2

4.2

14.78

14.69

pmol/l

1.66

4131

36377

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

352

1472

2.48

52.35

3.8

2.5

3.51

3.58

g/l

0.37

334

1392

(3009261) Glucose [Presence] in Urine by Test strip

3117

24995

1.51

52.31

5.8

3.6

0.01

0.00

estimate

0.19

533

4656

(3013512) EKG study

1883

13568

1.56

51.90

4.9

3.7

—

(3002582) Erythrocytes [#/volume] in Urine

1991

14547

1.55

51.48

5.2

3.1

64.83

84.31

e6/l

0.44

1609

11058

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1503

10297

1.61

51.30

1.8

1.6

23445440.59

32801457.71

pmol/l

0.31

1254

8579

(3021601) Nitrite [Presence] in Urine by Test strip

3084

24737

1.51

51.26

7.5

4.8

0.00

estimate

0.80

551

4741

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

239

834

2.94

50.72

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

150

6.01

50.47

2.1

1248.58

24374.19

u/ml

0.55

(3033658) Prothrombin time (PT) actual/Normal

1738

12360

1.57

50.45

6.8

3.7

92.34

91.69

0.50

1686

12030

(3015171) Extractable nuclear Ab [Units/volume] in Serum

438

2049

2.23

50.33

1.3

0.42

1.12

u/ml

1.71

183

(3009508) Creatinine [Moles/volume] in Urine

1985

14556

1.54

50.18

4.0

3.2

7.01

7.41

mmol/l

3.11

1658

12342

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

427

1990

2.23

49.50

6.0

2.6

0.68

0.64

1.13

427

1976

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

398

1803

2.29

49.38

2.4

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

1480

10185

1.60

49.25

4.1

2.5

5.96

6.42

e6/l

0.62

1368

9087

(3025941) Bacteria identified in Stool by Culture

563

2930

2.02

48.90

1.5

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5468

50265

1.95

48.82

29.6

13.1

23.05

22.47

mg/l

0.70

4707

39589

(3000570) Elastase.pancreatic [Mass/mass] in Stool

330

1389

2.46

48.35

1.5

1.4

282.10

286.35

ug/g

0.13

199

772

(3011397) Hemoglobin [Presence] in Urine by Test strip

1636

11584

1.57

47.94

5.6

3.6

—

(40758558) Short blood count panel - Blood

1747

12578

1.55

47.42

11.7

6.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1331

9010

1.61

47.13

1.9

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

301

1235

2.51

46.57

1.7

1.5

6.12

15.02

iu/ml

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

453

2214

2.13

46.54

9.8

4.0

23.90

24.14

mmol/l

0.89

445

2171

(3037756) Immunofixation for Serum or Plasma

237

867

2.80

46.11

1.8

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1217

8105

1.63

45.91

4.0

2.6

1.16

1.21

e6/l

0.16

734

4543

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

165

491

3.43

45.73

2.3

1.5

—

(3028433) Virus identified in Specimen by Culture

148

5.74

45.52

1.1

—

(40761535) Cells panel - Urine sediment

677

3860

1.85

44.58

5.5

3.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

330

1445

2.36

44.24

4.9

3.1

0.31

0.35

u/ml

1.02

205

824

(3008536) Aspergillus sp Ab [Presence] in Serum

7.79

44.17

2.3

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

194

4.96

43.75

1.5

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

347

1561

2.30

43.70

1.7

1.6

341.54

400.29

titre

0.11

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

517

2721

1.98

43.33

2.1

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

257

1015

2.60

43.02

1.8

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

560

3039

1.93

42.90

3.1

2.3

—

(3017181) Myelocytes/100 leukocytes in Blood

698

4066

1.81

42.77

5.6

4.1

0.98

0.90

0.41

385

1319

(3006245) CD3-CD19+ cells/100 cells in Blood

191

4.93

42.55

1.8

2.2

10.53

9.02

0.48

176

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

351

1605

2.26

42.50

1.8

1.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

691

4026

1.81

42.29

1.6

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

234

896

2.68

41.68

1.9

1.5

—

(3019150) Specific gravity of Urine by Refractometry

1490

10633

1.53

41.02

6.3

3.9

1.01

1.02

kg/l

3.49

231

1647

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

886

5588

1.69

40.88

4.7

2.6

7.88

7.81

umol/l

0.03

741

4803

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

395

1927

2.12

40.67

5.5

3.7

49.95

48.59

0.50

389

1904

(3012516) Albumin [Mass/volume] in Urine

1787

13274

1.49

40.53

4.0

3.2

627.53

356.04

mg/l

1.27

1194

8324

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1285

8898

1.56

40.45

1.3

41.04

30.78

iu/ml

1.16

399

2819

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

460

2398

1.99

39.52

16.7

9.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1854

13932

1.48

39.45

4.5

3.8

13.85

9.04

mg/mmol

2.66

1216

8701

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5123

46772

1.64

39.40

6.3

4.9

1.84

2.03

mu/l

2.04

4684

43121

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

324

1482

2.25

39.18

1.3

34.57

38.65

u/ml

0.10

(3003327) Ova and parasites identified in Stool by Light microscopy

358

1713

2.16

38.72

1.9

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

260

1088

2.45

38.53

1.8

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

222

4.38

38.03

2.2

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

222

4.38

38.03

2.2

1.5

—

(3022145) Colonoscopy Study observation

855

5438

1.67

37.99

1.4

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

753

4634

1.71

37.86

3.2

2.4

34.99

47.32

u/l

0.61

647

3960

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

176

610

2.94

37.83

1.9

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

208

789

2.69

37.75

1.6

0.74

0.75

g/l

0.01

150

607

(3005988) Vibrio sp identified in Specimen by Organism specific culture

176

613

2.93

37.50

1.9

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

175

610

2.92

37.23

1.9

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

178

627

2.89

37.16

1.9

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

576

3299

1.82

37.09

2.1

1.8

—

(3003181) Sodium [Moles/volume] in Urine

210

809

2.65

36.97

1.9

1.3

60.61

64.23

mmol/l

0.56

170

651

(3004809) Band form neutrophils/100 leukocytes in Blood

197

735

2.74

36.93

3.8

3.3

1.55

1.50

0.06

172

659

(3048929) Epstein Barr virus Ab [Presence] in Serum

344

1658

2.14

36.50

1.4

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

175

618

2.89

36.37

1.9

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

242

1007

2.46

36.30

5.8

3.7

8.30

8.35

kpa

0.19

237

982

(3024522) Salmonella sp identified in Specimen by Organism specific culture

175

619

2.88

36.26

1.9

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

327

1556

2.16

35.84

3.2

2.2

90.19

92.78

1.07

318

1489

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

176

4.71

35.64

2.2

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

176

4.71

35.64

2.2

1.6

—

(3042631) Mycobacterium sp identified in Specimen

164

566

2.95

35.53

3.1

2.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

307

1430

2.21

35.49

3.6

2.5

193.13

184.74

0.82

291

1360

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1416

10259

1.50

35.44

1.8

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

177

4.68

35.40

2.2

1.6

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

150

493

3.09

35.40

1.5

1.3

2.95

2.88

g/l

0.16

103

351

(3021901) Oxygen saturation in Capillary blood

198

762

2.65

34.93

3.6

3.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

234

976

2.45

34.93

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

234

976

2.45

34.93

1.6

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

434

2314

1.94

34.84

15.1

9.1

24.07

24.29

mmol/l

0.61

416

2249

(3024139) IgG subclass 3 [Mass/volume] in Serum

149

493

3.07

34.77

1.5

1.3

0.40

0.41

g/l

0.17

103

349

(3027135) IgG subclass 1 [Mass/volume] in Serum

149

494

3.07

34.65

1.5

1.3

7.03

6.84

g/l

0.17

102

350

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

498

2786

1.86

34.50

13.8

7.1

24.78

24.82

mmol/l

0.08

492

2768

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

122

5.46

34.03

1.4

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

290

1345

2.21

33.88

1.4

1.3

3.74

5.57

u/ml

0.31

136

(4062490) Immunoglobulin typing, IgG

147

491

3.04

33.75

1.5

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

244

1054

2.37

33.70

1.4

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

292

1364

2.20

33.51

1.4

1.3

5.57

9.27

u/ml

0.85

216

(3002179) Metamyelocytes/100 leukocytes in Blood

621

3743

1.73

33.45

5.2

3.9

0.92

0.66

1.06

325

1155

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

250

1099

2.33

33.18

1.3

1.82

2.79

u/ml

0.39

(3008757) Leukocyte morphology finding [Identifier] in Blood

146

492

3.02

33.02

3.5

3.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1087

7550

1.54

32.93

4.4

2.8

3.16

3.06

e6/l

0.12

614

4010

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

268

1221

2.25

32.69

5.8

3.6

1.73

1.47

mg/l

3.87

250

1127

(3017732) Neutrophils [#/volume] in Blood

584

3482

1.75

32.66

3.3

2.7

6.41

4.89

e9/l

0.92

400

2864

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

209

854

2.50

32.61

1.3

1.2

172.00

196.00

titre

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

183

702

2.66

32.51

2.6

1.8

2.46

3.30

titre

—

(3042733) HLA Ab [Presence] in Serum

128

5.20

32.29

5.0

4.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

231

993

2.38

32.26

1.4

1.2

298.47

269.92

u/ml

0.73

152

615

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

246

1089

2.31

32.12

1.3

1.2

0.82

8.24

u/ml

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

305

1476

2.12

31.99

1.4

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

915

6156

1.57

31.87

1.9

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

308

1501

2.11

31.72

1.5

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3861

33845

1.39

31.40

3.8

3.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

175

4.44

31.23

3.7

2.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

631

3892

1.69

31.15

5.5

4.1

0.17

0.12

0.99

318

1144

(3014765) Yersinia sp identified in Stool by Organism specific culture

305

1493

2.10

31.05

1.4

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

674

4238

1.66

30.92

2.3

1.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

234

1033

2.32

30.76

1.8

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

615

3786

1.70

30.55

3.0

2.6

65.05

67.86

ml/min/173m2

0.91

294

1485

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

116

5.30

30.52

1.2

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1181

8482

1.49

30.19

1.3

12.71

11.23

u/ml

0.24

405

3347

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1239

8986

1.48

30.15

5.1

3.5

221.14

503.41

ng/l

1.63

923

6680

(3036489) Thrombin time

355

1856

1.97

30.12

3.0

2.0

21.35

21.41

0.07

317

1596

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

877

5928

1.56

29.76

1.9

1.7

1.54

1.42

5.06

754

5254

(1616796) Gas panel - Central venous blood

228

1013

2.30

29.53

5.7

3.4

—

(4035726) Immunohistochemistry procedure

668

4240

1.65

29.47

1.6

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

605

3751

1.68

29.21

3.8

2.9

219.01

185.13

ng/l

1.02

547

3405

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

270

1296

2.13

28.92

1.9

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

214

934

2.34

28.89

1.9

1.4

134.30

111.00

u/ml

0.45

197

(3034860) Kappa light chains.free [Mass/volume] in Serum

279

1357

2.11

28.88

4.3

3.2

56.72

96.77

mg/l

0.47

228

1112

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

107

326

3.32

28.68

1.6

1.5

25.21

20.26

u/ml

0.40

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

144

522

2.80

28.57

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

278

1357

2.10

28.51

4.3

3.2

53.81

55.81

mg/l

0.06

230

1110

(3000060) B lymphocytes [#/volume] in Blood

140

4.68

28.19

1.7

2.1

177.43

149.73

e6/l

0.26

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

271

1317

2.11

28.11

4.3

3.2

2.71

1.98

ratio

0.19

112

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1208

8823

1.46

28.10

3.5

2.9

2.46

2.45

mmol/l

0.86

1043

7699

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

179

730

2.50

28.08

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

195

3.99

27.14

4.7

3.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5398

50770

1.61

27.11

31.7

14.7

139.12

139.63

mmol/l

36.50

5266

49429

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

154

594

2.63

27.11

2.1

1.6

5320.00

1717.33

titre

0.40

(40760888) Immunoglobulin light chains.free panel - Serum

222

1012

2.24

27.06

4.1

3.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5408

50910

1.61

26.78

31.8

14.9

3.95

mmol/l

0.34

5268

49463

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

342

1837

1.91

26.77

8.2

5.2

1.67

1.64

0.19

321

1713

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

110

356

3.13

26.73

1.4

1.2

1.24

1.70

u/ml

0.32

181

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2314

19018

1.35

26.55

6.2

3.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

279

3.41

26.29

1.6

1.3

—

(3047181) Lactate [Moles/volume] in Blood

287

1461

2.01

26.26

9.2

6.2

1.40

1.26

mmol/l

1.34

256

1281

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

286

3.36

25.98

1.6

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.50

25.96

1.5

1.9

—

(40768443) Skin Pathology biopsy report

381

2147

1.83

25.66

1.3

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

371

2076

1.84

25.56

2.2

1.9

41.48

39.23

u/l

1.20

332

1862

(3017354) Segmented neutrophils/100 leukocytes in Blood

127

459

2.80

25.38

3.5

3.1

59.33

56.98

0.51

108

398

(3007930) Methemoglobin/Hemoglobin.total in Blood

335

1826

1.88

25.07

8.4

5.3

0.95

0.89

316

1707

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

233

1118

2.13

25.00

1.3

1.2

38.82

40.91

u/ml

0.08

120

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

179

772

2.36

24.87

1.4

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

215

1006

2.18

24.60

2.7

2.1

123.92

128.41

g/l

1.71

147

724

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

116

407

2.89

24.50

5.0

3.9

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

264

3.37

24.23

2.0

1.4

—

(3025159) Blasts/100 leukocytes in Blood

576

3696

1.62

24.13

5.4

4.1

0.91

0.33

0.60

259

957

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

323

1763

1.88

24.07

2.0

1.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

281

3.27

23.93

1.2

1.4

80.00

66.00

titre

—

(36660697) Celiac disease serology panel - Serum

648

4284

1.57

23.93

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

145

579

2.54

23.82

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

206

3.67

23.61

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

206

3.67

23.61

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

230

3.51

23.53

2.1

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

277

1448

1.96

23.50

4.5

3.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

233

3.47

23.08

2.1

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

540

3449

1.62

23.02

3.3

4.30

4.48

pmol/l

4.43

458

3069

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

117

427

2.77

22.99

3.1

2.9

—

(3008295) Osmolality of Serum or Plasma

130

503

2.62

22.80

1.5

1.4

282.99

277.77

mosm/kgh2o

1.55

391

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

150

623

2.44

22.68

2.7

2.5

—

(3004616) Nuclear Ab [Presence] in Serum

153

644

2.41

22.47

1.4

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

282

3.19

22.46

1.5

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

291

1571

1.90

22.43

1.7

1.6

1.02

4.80

iu/ml

0.50

334

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.35

21.78

2.6

1.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

219

3.45

21.57

3.7

1.7

2.05

1.95

umol/l

0.33

206

(3016038) Potassium [Moles/volume] in Urine

300

3.06

21.50

1.8

1.2

30.42

34.57

mmol/l

1.12

259

(3029937) Albumin [Presence] in Urine by Test strip

1652

13222

1.34

21.48

6.8

3.9

0.00

estimate

2.17

527

4619

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

336

1928

1.79

21.29

1.6

1.7

—

(3024928) Oxygen saturation in Venous blood

198

950

2.12

21.29

8.5

2.8

—

(21494814) CD8 cells/100 lymphocytes in Specimen

188

3.65

21.24

2.1

2.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

252

1323

1.94

21.13

1.4

1.1

—

(3039000) Anion gap in Blood

207

1013

2.08

21.13

11.1

7.3

11.40

11.21

mmol/l

0.34

190

903

(3018572) Chloride [Moles/volume] in Blood

207

1014

2.08

21.07

11.1

7.3

104.47

105.21

mmol/l

1.07

190

904

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

267

1433

1.90

20.96

1.4

—

(3024471) HLA-A [Type]

132

4.20

20.89

1.0

—

(1761868) Lipid panel - Serum or Plasma

1418

17700

0.74

20.81

2.9

2.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

141

4.07

20.81

3.3

2.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4804

44657

1.37

20.78

7.2

5.4

40.81

39.20

mmol/mol

17.28

4410

41352

(3007566) Smooth muscle Ab [Titer] in Serum

256

1360

1.92

20.73

1.3

1.2

170.48

96.32

titre

0.58

114

(40768446) Kidney Pathology biopsy report

182

3.66

20.70

2.3

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

195

942

2.11

20.60

3.6

2.3

15.55

16.24

1.56

119

464

(3016650) Hepatitis A virus Ab [Presence] in Serum

174

806

2.19

20.46

1.2

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

696

4828

1.50

20.46

3.7

3.9

34.81

34.77

ug/l

0.00

567

3842

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

188

898

2.13

20.46

1.6

1.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

179

3.66

20.43

2.6

2.0

79.70

58.27

ug/l

0.87

172

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

6.06

20.27

1.1

27.07

40.64

mg/l

0.99

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

175

816

2.18

20.25

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

295

1653

1.82

20.23

3.8

3.1

0.62

0.29

g/l

1.27

152

666

(3013139) Helicobacter pylori Ag [Presence] in Stool

529

3465

1.58

20.22

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

164

746

2.23

20.17

2.3

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

188

905

2.11

20.06

4.9

2.7

—

(3024932) HLA-DR beta [Type]

130

4.10

19.58

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

408

2528

1.66

19.57

2.5

2.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

244

1304

1.91

19.42

2.1

2.0

11.39

11.37

mg/l

0.01

227

1207

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5550

53112

1.57

19.30

17.5

9.9

25.34

25.56

u/l

0.42

5380

51218

(3035637) Corticotropin [Mass/volume] in Plasma

141

615

2.32

19.17

1.8

1.5

—

(3016228) CD19 cells/100 cells in Blood

197

3.43

19.11

2.2

2.0

6.61

8.59

0.91

188

(3001964) Herpes simplex virus Ag [Presence] in Specimen

142

3.90

18.97

1.8

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

237

3.15

18.41

2.5

21.48

22.16

umol/l

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

285

2.94

18.32

2.7

1.4

15.30

23.05

umol/l

2.80

271

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

120

499

2.43

18.18

1.3

1.2

62.94

61.90

u/l

0.05

107

454

(3000492) Spirometry study

684

4845

1.46

18.00

1.7

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

293

1698

1.76

17.96

1.5

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

338

2.75

17.94

2.2

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

247

1364

1.85

17.77

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4976

46803

1.36

17.71

22.3

12.1

83.34

83.24

ml/min/173m2

0.10

4196

38516

(3042517) Benzodiazepines panel - Urine

6.33

17.53

3.6

2.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

102

401

2.57

17.41

1.2

92.33

62.63

u/ml

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

296

1736

1.74

17.41

3.1

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

296

1737

1.74

17.37

3.1

2.2

7.58

7.43

g/l

0.77

263

1566

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

138

623

2.24

17.34

1.0

1.1

1.51

g/l

0.02

120

562

(3011288) Drugs identified in Urine by Screen method

252

1420

1.81

16.99

5.6

2.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

213

1140

1.90

16.91

1.3

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

294

1736

1.73

16.88

3.1

2.2

3.63

3.64

g/l

0.05

261

1567

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

278

1617

1.75

16.83

3.2

2.3

9.64

10.22

g/l

1.17

242

1436

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

101

404

2.53

16.65

1.2

34.50

43.58

u/ml

0.18

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

148

3.60

16.39

2.1

2.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

278

1631

1.74

16.34

3.2

2.3

2.97

2.96

g/l

0.09

245

1462

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

520

3554

1.51

16.31

2.5

2.4

16.58

23.87

au/ml

1.49

288

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

483

3254

1.53

16.21

1.4

1.3

60.97

53.48

au/ml

0.22

169

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

158

779

2.06

15.89

1.2

3.88

4.65

u/ml

0.47

321

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

337

2.63

15.88

1.3

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

148

715

2.10

15.72

2.8

1.8

1.56

1.65

mmol/l

0.68

143

696

(1001926) Buprenorphine [Presence] in Urine by Screen method

274

1619

1.73

15.71

4.2

2.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

102

423

2.44

15.60

1.2

1.1

—

(3012501) Base excess in Blood by calculation

195

1042

1.90

15.58

7.5

3.9

2.70

2.59

mmol/l

0.17

144

688

(3013290) Carbon dioxide [Partial pressure] in Blood

195

1042

1.90

15.58

7.5

3.9

4.95

5.02

kpa

0.48

189

1025

(21494890) Protein electrophoresis panel - 24 hour Urine

105

442

2.40

15.54

2.3

1.9

—

(3027315) Oxygen [Partial pressure] in Blood

195

1047

1.89

15.36

7.5

3.9

8.70

8.68

kpa

0.03

189

1029

(3016879) Cocaine [Presence] in Urine

312

1923

1.66

15.28

4.2

2.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

138

657

2.13

15.24

1.3

36.06

50.97

u/ml

0.41

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

127

586

2.19

15.18

2.3

2.1

24.96

22.73

mg/l

0.13

149

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

335

2.59

15.02

1.3

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

101

425

2.40

14.98

1.2

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

109

476

2.31

14.87

2.7

2.3

0.98

1.39

g/24h

0.75

234

(40761511) CBC panel - Blood by Automated count

5460

52435

1.44

14.79

25.3

12.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

386

2.46

14.71

1.2

4.00

5.91

u/ml

0.24

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

190

3.13

14.62

4.4

—

(3032057) Clostridioides difficile [Presence] in Stool

4.13

14.61

2.3

1.9

—

(3010421) pH of Blood

217

1226

1.80

14.55

7.6

3.9

7.42

0.16

195

1115

(3019420) Tryptase [Mass/volume] in Serum or Plasma

289

2.69

14.49

1.3

1.5

7.30

8.07

ug/l

0.21

252

(3003434) Protein [Mass/volume] in Pleural fluid

120

553

2.19

14.41

1.5

32.09

32.63

g/l

0.15

105

501

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

251

1489

1.72

14.21

3.3

2.3

0.75

0.89

g/l

0.34

216

1288

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

321

2.58

14.20

1.1

1.0

—

(3051651) Icteric interference index of Serum or Plasma

288

2.66

14.05

6.5

3.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

283

2.67

13.98

1.1

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

324

2.55

13.94

1.1

1.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

182

988

1.87

13.89

4.8

3.5

58.43

57.54

0.37

182

988

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

333

2138

1.59

13.84

1.1

1.03

1.49

u/ml

—

(3051611) Lipemic interference index of Serum or Plasma

108

485

2.25

13.83

5.4

3.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

148

753

1.99

13.70

1.1

117.56

116.94

0.07

135

670

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

315

2.56

13.70

1.6

1.3

—

(3014271) Vancomycin [Susceptibility]

226

2.85

13.53

3.6

2.8

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

237

2.80

13.53

1.3

1.2

214.81

351.38

u/l

1.05

222

(3006922) Hepatitis E virus Ab [Presence] in Serum

341

2.48

13.51

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

184

3.06

13.45

5.7

5.0

55.68

61.47

mg/l

0.44

127

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

6.07

13.38

1.7

3.16

1.41

mg/l

—

(3000764) Benzodiazepines [Presence] in Urine

321

2061

1.59

13.34

4.3

2.0

—

(3028300) Cannabinoids [Presence] in Urine

324

2085

1.59

13.34

4.2

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

142

722

1.99

13.19

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

406

2754

1.51

13.18

1.5

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

117

554

2.13

13.16

1.6

1.5

38.80

24.60

iu/ml

—

(40768441) Liver Pathology biopsy report

352

2.43

13.11

1.6

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

244

1472

1.69

13.01

1.4

1.3

13.12

10.55

u/l

1.33

184

1219

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

384

2.36

13.00

1.2

1.3

2.31

2.03

mmol/l

1.09

357

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

116

551

2.13

12.95

1.1

90.41

95.76

1.33

110

517

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.45

12.81

6.0

6.5

—

(3027008) Opiates [Presence] in Urine

320

2080

1.57

12.63

4.2

2.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

341

2.42

12.55

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

219

2.80

12.54

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

242

2.70

12.48

2.3

1.8

154.00

139.55

0.61

231

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

177

3.01

12.41

1.4

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

194

1113

1.77

12.40

1.4

1.3

3.89

3.71

mmol/l

1.11

176

1036

(3024666) Lithium [Moles/volume] in Serum or Plasma

301

2.51

12.39

15.3

11.8

0.69

0.61

mmol/l

1.12

276

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

382

2592

1.51

12.39

2.7

2.2

6091.16

5827.32

u/l

0.04

142

1060

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

413

2851

1.48

12.31

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

150

801

1.89

12.10

1.2

4.39

3.88

u/ml

0.14

258

(3052592) Norovirus Ag [Presence] in Stool

4.04

12.08

1.6

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

242

1486

1.65

12.08

1.1

5.57

6.20

u/ml

0.11

187

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

330

2.41

11.99

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

154

834

1.87

11.90

2.4

2.0

5.54

6.76

umol/l

0.59

113

606

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

212

1264

1.70

11.84

1.4

1.3

622.95

510.44

mg/l

0.41

199

1191

(3027944) Amphetamines [Presence] in Urine

312

2047

1.55

11.83

3.7

1.9

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.12

11.72

1.3

1.1

—

(3048879) Bone marrow aspiration report

112

3.50

11.65

2.1

1.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

162

898

1.83

11.64

2.2

2.0

4.81

5.04

mmol/24h

0.40

141

789

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.59

11.63

13.5

12.1

5.70

5.97

mmol/l

0.13

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

217

2.74

11.62

1.8

1.9

104.59

148.93

umol/l

0.63

115

(3023199) Leukocytes [#/volume] in Pleural fluid

105

503

2.11

11.52

1.6

1.4

5303.30

1988.62

e6/l

0.50

372

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.18

11.50

2.1

1.4

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.69

11.46

1.7

1.61

0.52

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.69

11.46

1.7

2.07

1.91

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.69

11.46

1.7

4.06

4.35

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.69

11.46

1.7

3.75

1.08

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.69

11.46

1.7

0.84

0.82

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.69

11.46

1.7

3.03

1.98

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.69

11.46

1.7

3.24

1.44

mg/l

0.40

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.69

11.46

1.7

4.14

2.42

mg/l

0.58

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.69

11.46

1.7

1.61

0.69

mg/l

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

381

2.28

11.45

1.3

1.2

92.63

189.88

titre

1.78

(3000012) Reticulocyte production index

117

585

2.02

11.45

2.5

2.1

—

(3049717) Cytology report of Urine Cyto stain

244

1525

1.63

11.38

2.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

427

2.20

11.36

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.38

11.33

1.3

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

4.12

11.30

2.3

1.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

397

2.23

11.23

1.2

1.4

1.43

1.49

nmol/l

0.20

361

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

645

4895

1.36

11.21

5.2

3.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

223

1370

1.65

11.14

3.0

2.1

36.37

37.84

g/l

2.34

187

1200

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

530

3904

1.39

11.08

1.2

105.85

150.92

iu/ml

2.26

187

1475

(3030981) Hyaline casts [#/volume] in Urine by Automated count

347

2363

1.50

11.07

3.9

2.6

0.41

0.27

e6/l

0.80

337

2295

(3009466) Valproate [Moles/volume] in Serum or Plasma

125

650

1.94

10.96

6.0

5.2

344.74

363.46

umol/l

0.68

107

568

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

166

947

1.77

10.87

3.4

1035.39

710.47

u/ml

0.17

148

864

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

237

2.59

10.82

1.7

1.9

—

(3045142) Bone marrow Pathology biopsy report

102

496

2.07

10.78

1.5

1.3

—

(3017704) Immunofixation for Urine

232

2.60

10.75

1.9

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

177

1036

1.73

10.61

1.5

1.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

115

3.32

10.51

1.6

1.7

314.24

102.59

au/ml

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

295

2.39

10.47

1.7

1.5

7.73

6.03

u/l

0.38

242

(3028308) Erythrocytes [#/volume] in Pleural fluid

450

2.11

10.37

1.7

1.4

29610.38

74651.92

e6/l

1.28

263

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

107

538

2.01

10.35

2.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

191

2.74

10.31

1.3

1.1

—

(21494434) Karyotype in Bone marrow

386

2.19

10.28

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

164

948

1.75

10.28

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

292

2.38

10.24

1.4

1.5

14.00

12.99

u/l

0.46

280

(3006653) Thiamine [Moles/volume] in Blood

250

2.50

10.21

1.3

133.85

133.40

nmol/l

0.02

250

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4986

47702

1.26

10.21

5.4

4.3

6.06

5.85

mmol/l

13.22

4509

43605

(3021387) Prolactin [Units/volume] in Serum or Plasma

309

2093

1.50

10.14

1.8

1.6

347.53

303.47

mu/l

0.92

268

1871

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

136

747

1.84

10.12

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

450

2.08

9.99

1.4

1.5

—

(3047189) Immunofixation for 24 hour Urine

201

2.65

9.90

1.7

1.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

151

2.93

9.89

2.1

1.9

9.07

9.47

mg/l

0.13

123

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

274

2.39

9.75

1.4

1.2

49.43

19.85

u/l

2.09

233

(40761539) Cells [Type] in Urine sediment by Light microscopy

106

3.32

9.69

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

145

824

1.78

9.66

1.2

1.1

21.15

11.61

au/ml

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

246

2.45

9.57

1.2

1.1

31.78

23.30

u/l

0.42

223

(3012441) Differential panel - Pleural fluid

418

2.10

9.54

1.6

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

182

2.71

9.54

1.3

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

247

2.44

9.49

1.2

1.1

88.87

79.17

u/l

0.42

224

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

196

1216

1.63

9.47

3.3

2.2

0.01

0.00

g/l

0.50

180

1117

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

136

763

1.80

9.47

1.2

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

208

1311

1.61

9.43

3.2

2.2

0.04

0.02

g/l

0.46

192

1207

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

232

2.47

9.24

1.9

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

232

2.47

9.24

1.9

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

128

711

1.82

9.22

1.3

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

128

713

1.81

9.14

1.8

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

193

1204

1.62

9.14

3.3

2.2

0.00

g/l

-0.00

179

1116

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

283

2.31

9.09

1.4

1.2

119.15

83.04

u/l

1.92

246

(3036782) Glucose [Moles/volume] in Pleural fluid

401

2.08

9.00

1.3

1.4

6.50

6.35

mmol/l

0.18

375

(4146454) Self-monitoring of blood glucose

484

1.98

8.91

2.6

2.7

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

357

2.14

8.87

2.5

1.8

4.91

4.00

mg/l

0.56

343

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

262

2.34

8.81

1.1

—

(3021589) Normoblasts [#/volume] in Blood

2457

22190

1.18

8.79

17.1

9.0

0.00

e9/l

0.13

2035

18101

(3002256) Pathology report gross observation

808

6534

1.27

8.78

1.4

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

137

792

1.75

8.65

1.1

—

(40765096) Chromosome analysis panel by Banding

141

2.85

8.61

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

350

2509

1.42

8.59

1.1

258.00

160.68

titre

—

(3023511) Choriogonadotropin [Units/volume] in Urine

207

1340

1.56

8.42

1.5

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

379

2765

1.40

8.41

2.5

2.1

11.31

11.86

nmol/l

0.55

332

2462

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

123

698

1.78

8.30

1.4

1.2

39.43

39.51

u/l

0.00

105

607

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

8.52

8.29

2.9

2.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

355

2.10

8.21

1.6

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

513

1.91

8.20

9.2

5.9

7.19

7.14

mmol/l

0.05

423

(3035947) Staphylolysin Ab [Units/volume] in Serum

216

2.42

8.12

1.2

1.1

3.33

3.85

iu/ml

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

166

1029

1.63

8.11

2.5

2.3

75.14

95.43

ug/min

0.48

101

613

(3041096) Erythrocytes [Presence] in Urine by Automated

1555

13578

1.20

8.05

5.1

3.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

512

3948

1.32

7.97

7.2

3.5

1.22

1.23

mmol/l

1.37

454

3411

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

218

2.40

7.97

7.6

5.9

39.75

97.54

u/ml

0.73

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

400

2.01

7.96

1.3

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.84

7.95

1.1

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.14

7.93

10.2

6.9

—

(3036180) Methadone [Presence] in Urine

231

2.35

7.91

2.9

1.9

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

288

2.20

7.91

1.3

1.6

5.45

6.61

u/l

0.84

246

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.70

7.88

1.1

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

276

2.22

7.85

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

166

2.60

7.83

2.9

2.8

8.66

7.90

mg/l

0.29

134

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

144

2.72

7.74

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.18

7.72

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

364

2.05

7.71

1.7

1.4

1.19

1.17

promille

0.04

288

(3023323) Follitropin [Units/volume] in Serum or Plasma

372

2752

1.37

7.61

1.5

1.3

27.91

25.97

iu/l

0.48

298

2360

(3035880) pH of Pleural fluid

229

2.33

7.61

1.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

442

1.94

7.58

1.3

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

136

818

1.68

7.50

3.7

3.1

0.85

0.82

nmol/l

0.29

623

(3004451) EKG impression Narrative

207

2.38

7.41

1.5

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

154

2.61

7.34

1.3

1.5

57.58

64.09

0.51

127

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

126

2.79

7.30

1.3

135.35

127.74

nmol/l

0.08

(40757373) Influenza virus identified in Isolate

3.09

7.26

1.8

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

143

882

1.64

7.17

1.3

1.4

26.40

25.47

u/l

0.11

109

740

(40768806) Pleura Pathology biopsy report

430

1.92

7.16

1.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.93

7.15

2.7

2.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

145

899

1.63

7.13

2.0

2.1

0.94

0.82

nmol/l

1.08

116

758

(3033923) Metanephrine [Moles/time] in 24 hour Urine

101

2.98

7.06

1.1

0.56

0.70

umol/24h

—

(3045788) Cell count panel - Pleural fluid

405

1.94

7.02

1.6

1.5

—

(3045424) Erythrocytes [Presence] in Urine

137

841

1.64

7.01

1.7

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

252

2.19

6.91

1.6

1.5

1.52

1.28

nmol/l

0.71

197

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

177

2.44

6.90

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

286

2.11

6.84

1.3

12.30

11.65

u/l

0.14

263

(3011985) Renin [Units/volume] in Plasma

107

619

1.74

6.83

2.3

1.5

81.53

50.95

mu/l

0.41

546

(4034850) Laboratory test

227

1570

1.46

6.82

12.9

9.3

—

(3003694) ABO and Rh group [Type] in Blood

1669

14836

1.17

6.81

1.6

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

144

905

1.61

6.72

4.8

2.6

—

(3012565) Volume of 24 hour Urine

238

2.20

6.57

2.7

2.3

2051.64

1926.07

0.30

213

(3011648) Oxygen content in Venous blood

366

1.95

6.55

3.7

2.3

10.76

11.21

0.36

366

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

401

1.91

6.55

2.6

1.7

—

(3016244) Insulin [Units/volume] in Serum or Plasma

318

2.02

6.55

3.3

3.2

36.36

26.71

mu/l

0.85

304

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

187

1258

1.50

6.47

1.3

1.2

—

(3017569) Oxygen content in Arterial blood

208

2.27

6.44

2.0

2.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

183

2.36

6.44

1.1

1.0

—

(3006576) Bicarbonate [Moles/volume] in Blood

141

2.56

6.43

7.7

6.2

24.03

24.23

mmol/l

0.08

128

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

153

2.49

6.41

2.7

2.4

145.88

126.33

au/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

167

1100

1.53

6.38

1.8

1.7

19264.26

11006.68

e6/l

1.11

129

782

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

301

2.04

6.37

1.3

4.64

5.11

umol/l

0.46

279

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

113

2.75

6.36

1.1

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

113

2.75

6.36

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

113

2.75

6.36

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

113

2.75

6.36

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

113

2.75

6.36

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.03

6.33

9.8

7.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

113

682

1.67

6.22

1.3

0.34

0.32

nmol/l

—

(37021550) Renin [Units/volume] in Plasma --upright

109

2.76

6.20

1.8

1.3

50.20

66.61

mu/l

0.39

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

139

2.53

6.09

1.4

1.1

—

(3025130) Human papilloma virus identified in Specimen

133

842

1.59

6.07

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

5688

55845

1.33

5.99

40.9

19.5

39.05

40.03

16.10

5371

52495

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.01

5.98

5.8

5.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

165

1102

1.51

5.94

1.7

1.4

119.37

4668.47

e6/l

0.74

139

874

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

165

1102

1.51

5.94

1.6

1.4

76.64

31.96

e6/l

0.27

134

819

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

185

2.28

5.85

1.2

0.32

0.29

g/l

1.24

149

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

8.01

5.83

2.6

1.1

—

(3007461) Platelets [#/volume] in Blood

5690

55890

1.32

5.78

40.3

19.5

259.14

255.82

e9/l

3.12

5577

54541

(3001893) Eosinophils/100 leukocytes in Pleural fluid

125

2.57

5.77

1.2

1.6

2.04

3.20

0.54

107

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

661

5476

1.23

5.76

1.6

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

279

2.02

5.74

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.87

5.72

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

6.10

5.68

1.1

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

169

2.32

5.65

1.2

86.70

89.55

0.17

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.88

5.61

1.5

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.88

5.61

1.5

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.88

5.61

1.5

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.40

5.57

2.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

8.47

5.55

1.0

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

5692

55938

1.32

5.54

40.5

19.6

130.35

134.43

g/l

78.60

5623

55181

(3024731) MCV [Entitic volume]

5690

55916

1.31

5.54

40.1

19.4

90.97

90.78

2.14

5620

55162

(3035941) MCH [Entitic mass]

5690

55917

1.31

5.53

40.1

19.4

30.16

30.22

1.41

5621

55159

(3010813) Leukocytes [#/volume] in Blood

5690

55922

1.31

5.48

40.3

19.5

7.07

6.73

e9/l

19.67

5571

54403

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.62

5.47

1.3

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

5690

55925

1.31

5.45

40.3

19.5

4.36

4.47

e12/l

54.88

5571

54425

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

249

1827

1.38

5.45

1.3

202.16

232.72

miu/ml

0.63

886

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

173

2.26

5.37

1.2

1.1

107.29

108.68

0.08

155

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

408

1.80

5.33

1.9

1.5

29.19

33.53

0.54

246

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

246

2.04

5.33

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.18

5.31

1.5

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.40

5.30

1.2

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

2.92

5.29

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.72

5.29

1.3

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

119

2.53

5.27

1.6

1.1

269.35

296.36

pmol/l

0.20

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

158

1074

1.48

5.27

1.1

1.65

2.29

u/ml

0.49

540

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

101

621

1.64

5.24

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.68

5.24

3.6

4.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

6.68

5.24

3.6

4.4

—

(3016018) Differential panel - Cerebral spinal fluid

553

1.67

5.21

1.6

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

244

1799

1.37

5.20

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.48

5.16

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

243

1794

1.37

5.14

1.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

250

2.01

5.11

1.1

3.90

6.14

u/ml

0.46

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.85

5.07

1.5

1.2

1.46

1.66

mmol/l

0.33

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

5.19

5.07

1.1

1.0

—

(3021788) Differential panel - Synovial fluid

126

825

1.54

5.04

1.7

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

238

2.02

5.03

2.4

1.7

1.47

3.42

u/field

1.11

165

(3006270) Folate [Moles/volume] in Blood

438

1.74

5.03

1.3

1.1

355.73

374.57

nmol/l

0.30

385

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

243

1801

1.36

5.02

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

120

778

1.55

5.01

1.1

80.64

718.67

iu/ml

0.50

196

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

243

1803

1.36

4.99

1.5

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1426

12782

1.15

4.97

1.8

1.6

1.52

1.37

mmol/l

5.15

1246

10784

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

129

2.41

4.95

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

133

885

1.51

4.94

1.1

1.99

1.50

u/ml

0.20

447

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

174

2.19

4.89

1.2

1.1

86.63

89.70

0.25

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

130

2.39

4.87

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

223

1642

1.37

4.82

3.3

3.4

139.87

3282.89

u/ml

1.13

186

1391

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

215

2.05

4.81

2.9

2.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

107

2.53

4.78

1.1

81.82

77.48

0.17

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.41

4.74

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

314

1.86

4.73

1.5

—

(3019977) pH of Arterial blood

231

2.00

4.68

2.4

3.0

7.43

7.42

0.23

(3008898) HLA-B27 [Presence]

256

1938

1.34

4.63

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.01

4.62

1.2

1.0

—

(3007463) Buprenorphine [Presence] in Urine

5.46

4.59

13.2

4.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

332

1.82

4.58

1.1

8.21

9.60

iu/ml

0.19

(3029075) Extractable nuclear Ab panel - Serum

153

2.23

4.58

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

147

2.25

4.55

1.2

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.86

4.48

2.1

1.6

53.04

40.20

pmol/l

0.28

(3026692) Albumin [Mass/volume] in Peritoneal fluid

111

2.44

4.45

1.3

1.5

11.11

12.96

g/l

0.37

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

157

1105

1.43

4.44

1.8

1.7

48.31

42.37

nmol/l

1.37

150

1069

(3008401) Mugwort IgE Ab [Units/volume] in Serum

135

925

1.47

4.40

1.1

0.73

1.21

u/ml

0.78

403

(21494755) Public health laboratory ask at order entry panel

409

5009

0.80

4.38

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

238

1.94

4.33

1.8

1.6

5.84

6.12

nmol/l

0.03

191

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

125

2.33

4.33

1.6

0.36

0.39

ug/l

0.14

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

168

1203

1.41

4.32

1.5

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

204

2.02

4.30

1.1

423.83

349.07

ng/l

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

134

921

1.47

4.30

1.4

1.5

0.48

0.44

nmol/l

0.15

742

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

536

1.61

4.30

1.9

1.6

60.67

57.56

0.35

329

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

101

2.48

4.28

1.4

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.78

4.27

1.4

1.5

4.32

450854.23

nmol/l

0.72

(3010144) Erythrocytes [#/volume] in Synovial fluid

422

1.69

4.27

1.4

72297.41

77400.89

e6/l

0.03

280

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

120

2.34

4.24

1.3

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.84

4.21

1.1

1.0

0.03

0.48

u/ml

0.52

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

108

2.41

4.21

1.1

73.33

70.96

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

199

2.02

4.21

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

146

2.20

4.20

1.4

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

111

739

1.51

4.18

1.2

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.81

4.18

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

134

2.24

4.14

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

2.99

4.11

1.0

0.10

0.86

u/ml

1.35

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.99

4.11

1.0

0.67

0.86

u/ml

0.11

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

374

1.72

4.10

1.1

1.0

291.25

288.73

mg/l

0.09

336

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

122

2.30

4.09

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.62

4.05

1.2

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

585

1.56

4.03

1.3

1.4

404.80

361.97

pmol/l

0.24

510

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

378

4612

0.81

3.93

1.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.45

3.87

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

123

851

1.45

3.86

1.2

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

299

1.78

3.86

1.3

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.77

3.84

1.5

1.3

1.55

1.51

mmol/l

0.01

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

255

1985

1.30

3.84

1.7

6.55

4.06

mg/l

1.45

190

1446

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4795

46651

1.14

3.84

4.5

3.7

1.32

1.27

mmol/l

4.90

4337

42848

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

405

1.66

3.82

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

405

1.66

3.82

1.3

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.27

3.82

6.9

8.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

406

1.66

3.79

1.3

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

12.01

3.76

1.2

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

339

1.72

3.75

1.0

1.1

3.54

1.35

u/ml

0.32

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

408

1.65

3.73

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

408

1.65

3.73

1.3

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.40

3.71

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

409

1.65

3.69

1.3

1.1

—

(1002224) Polysomnography panel

252

1970

1.29

3.69

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

122

851

1.44

3.69

1.2

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

104

704

1.49

3.66

1.1

5.04

3.48

u/ml

0.29

293

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.69

3.65

3.1

3.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

136

970

1.41

3.64

1.1

3.80

5.84

u/ml

0.87

511

(3030313) Adrenal Ab [Titer] in Serum

2.86

3.62

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

156

2.06

3.60

2.3

2.4

416.75

841.39

e6/l

1.20

115

(3045462) Protein/Creatinine [Ratio] in Urine

2.95

3.57

4.9

5.6

28.71

49.94

g/mol

0.51

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

515

1.56

3.56

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.78

3.55

4.4

8.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.81

3.51

1.0

0.75

7.51

u/ml

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

6.16

3.50

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.88

3.48

1.2

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

111

770

1.45

3.48

1.1

2.22

3.33

u/ml

0.80

355

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

363

2987

1.23

3.45

3.2

3.4

58.53

53.35

u/ml

0.11

344

2878

(3008116) Ketones [Moles/volume] in Urine by Test strip

100

2.30

3.42

2.1

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

123

873

1.42

3.41

1.1

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

267

1.77

3.39

1.1

3.83

22.67

u/ml

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.50

3.37

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.01

3.36

3.0

2.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

7.00

3.36

4.9

5.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.72

3.31

1.1

1.6

6.71

9.42

—

(3050794) Legionella sp Ab [Presence] in Serum

3.43

3.30

1.2

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.35

3.30

1.6

2.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.92

3.29

1.1

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.93

3.28

1.0

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

107

1511

0.70

3.28

1.8

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

135

2.08

3.27

2.1

2.0

11674.25

21695.13

e6/l

0.24

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

135

2.08

3.27

1.1

—

(3044941) Cell count panel - Synovial fluid

105

731

1.44

3.25

1.4

—

(3017509) Phencyclidine [Presence] in Urine

2.78

3.25

3.4

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.78

3.25

1.0

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5064

49566

1.14

3.23

5.3

4.6

2.65

2.79

mmol/l

24.88

4619

45867

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

4.17

3.19

1.5

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

6.37

3.18

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.80

3.18

1.0

1.6

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.36

3.14

1.1

1.2

0.41

0.30

u/ml

0.15

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.25

3.13

16.5

9.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

274

1.72

3.12

2.7

1.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

312

1.67

3.12

1.4

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.50

3.11

3.2

2.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

694

6106

1.15

3.10

1.9

1.8

—

(3020874) Milk IgE Ab [Units/volume] in Serum

336

1.64

3.08

1.0

1.1

0.40

2.01

u/ml

0.96

116

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

446

1.55

3.07

1.3

1.4

—

(3044889) 12 lead EKG panel

3510

33746

1.10

3.06

4.9

3.6

—

(3020491) Glucose [Moles/volume] in Blood

391

1.59

3.06

2.0

1.8

7.20

6.36

mmol/l

0.88

268

(3009871) Measles virus Ab [Titer] in Serum

160

1.94

3.03

1.5

1.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

5.84

3.02

1.1

1.0

—

(3034426) Prothrombin time (PT)

182

1.87

2.99

1.1

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.47

2.95

1.8

1.2

45.91

63.02

ng/l

0.16

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

246

1977

1.25

2.95

1.4

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

178

1374

1.30

2.94

1.6

1.9

4.16

4.52

iu/l

0.20

514

(40768795) Lymph node Pathology biopsy report

475

1.52

2.94

1.3

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

365

1.59

2.91

2.1

2.2

1.06

1.91

u/field

1.44

143

(3044242) Glucose [Moles/volume] in Arterial blood

213

1.79

2.91

1.9

2.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

108

2.13

2.89

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

142

1.98

2.89

2.4

1.4

9.22

8.51

ug/l

0.41

142

(3034891) Synovial lining cells/100 cells in Synovial fluid

207

1.79

2.85

2.0

1.4

3.18

4.02

0.17

(3051593) INR in Capillary blood by Coagulation assay

200

1.80

2.84

5.5

11.0

—

(3020393) Adenovirus Ag [Presence] in Stool

2.77

2.81

1.9

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.65

2.79

2.0

0.48

1.35

mmol/l

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.55

2.78

1.0

0.03

0.36

u/ml

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.58

2.78

1.2

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

498

1.49

2.77

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.92

2.77

1.9

1.2

—

(3033799) Differential panel - Peritoneal fluid

131

1.99

2.74

2.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

316

1.62

2.74

1.1

2.79

11.93

nmol/l

0.91

(43055514) Macroprolactin [Presence] in Serum or Plasma

145

1.94

2.74

1.4

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

210

1.77

2.73

1.4

1.3

138.43

153.98

mmol/24h

0.48

210

(3045414) Leukocytes [Presence] in Urine

278

2286

1.23

2.73

2.2

1.9

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.20

2.73

1.3

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

5.00

2.72

3.7

2.7

4.03

4.38

mmol/l

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.24

2.72

4.7

4.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4973

48730

1.12

2.72

4.9

4.2

4.57

4.71

mmol/l

19.44

4561

45337

(3020911) Cortisol [Moles/time] in 24 hour Urine

174

1.84

2.71

1.4

85.89

117.41

nmol/24h

0.36

174

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

444

1.51

2.71

1.1

1.4

9.86

8.30

mmol/l

1.72

435

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

428

1.52

2.70

1.2

1.1

41.84

39.13

mg/l

0.14

355

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

105

2.10

2.68

1.1

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

406

1.53

2.65

2.2

17.74

19.02

nmol/l

0.51

383

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.79

2.64

3.3

1.5

52.08

42.14

umol/l

0.29

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.39

2.62

1.1

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.39

2.62

1.4

1.5

0.28

0.39

nmol/l

0.27

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

630

1.42

2.59

1.1

1.0

0.08

0.23

u/ml

1.44

185

(1761482) Bacteria [#/volume] in Urine by Culture

149

1147

1.31

2.56

6.1

4.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.60

2.53

2.3

2.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

172

1.81

2.49

3.8

2.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

239

1956

1.23

2.48

1.5

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.32

2.48

1.0

0.49

0.14

u/ml

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.38

2.47

2.3

2.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

195

1.75

2.46

1.7

1.6

15.21

14.97

pmol/l

0.10

165

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

398

1.51

2.45

1.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.90

2.41

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

219

1.69

2.40

1.1

1.0

—

(3023410) Appearance of Cerebral spinal fluid

523

1.44

2.40

1.9

1.5

—

(3016135) IgD [Mass/volume] in Serum

6.25

2.37

1.0

1.3

28.20

105.89

mg/l

—

(3041354) Potassium [Moles/volume] in Venous blood

525

1.43

2.35

4.0

2.2

4.06

4.04

mmol/l

0.13

517

(3035285) Chloride [Moles/volume] in Venous blood

525

1.43

2.35

4.0

2.2

105.51

105.35

mmol/l

0.10

517

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4933

48404

1.11

2.35

4.9

4.1

1.48

1.49

mmol/l

1.97

4490

44794

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.22

2.30

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1184

10951

1.10

2.30

5.0

4.8

2.74

3.25

ug/l

0.49

1054

9806

(44813793) Dust mix specific IgE antibody measurement

372

1.51

2.29

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.38

2.29

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

512

1.43

2.28

4.1

2.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1092

10065

1.10

2.27

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.15

2.24

1.6

1.7

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

302

1.56

2.23

1.0

0.28

1.33

u/ml

0.58

(40761536) Microorganisms panel - Urine sediment

505

4454

1.15

2.23

6.7

3.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

416

1.47

2.21

1.1

279.98

253.12

mg/l

0.45

361

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

263

3124

0.83

2.19

1.3

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

661

1.37

2.17

1.3

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.69

2.15

1.9

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.10

2.12

1.8

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

152

1.78

2.11

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

119

918

1.30

2.08

1.3

2.54

3.66

ug/l

2.38

110

831

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.26

2.07

1.2

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.00

2.07

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

101

762

1.33

2.06

1.1

5.90

3.59

u/ml

0.40

360

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

549

1.39

2.04

5.0

4.8

33.37

68.21

u/ml

1.24

161

(3033086) Enterovirus NOS Ab [Titer] in Serum

4.00

2.04

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.00

2.04

5.0

5.3

684.50

404.40

umol/l

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.50

2.01

1.2

1.3

—

640.53

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

104

1.93

2.00

2.4

2.2

16.35

16.09

umol/l

0.04

104

(40768800) Prostate Pathology biopsy report

672

0.67

1.99

1.1

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

126

1.83

1.97

3.0

3.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

126

1.83

1.97

3.0

3.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

141

1.78

1.96

2.0

1.7

—

(3046861) Legionella sp Ag [Presence] in Urine

3.75

1.93

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

479

1.40

1.93

1.1

—

(3044007) Cell count panel - Peritoneal fluid

127

1.81

1.93

2.5

2.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.73

1.93

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

330

1.49

1.93

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

158

1.71

1.88

3.4

2.6

25.00

29.22

umol/l

1.12

112

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.65

1.86

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.65

1.86

1.9

2.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

174

1.67

1.85

1.1

7.35

6.66

u/ml

0.04

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

100

1.90

1.85

2.2

2.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

245

1.55

1.83

1.4

1.3

81.50

67.00

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.17

1.82

1.4

1.3

—

(3005033) Fetal Nuchal fold Thickness US

177

1460

1.22

1.80

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.34

1.77

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

665

0.69

1.76

1.5

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.09

1.75

1.1

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

177

1465

1.21

1.74

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

273

1.51

1.73

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.85

1.71

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

103

1.85

1.71

1.2

162.24

372.69

ug/l

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

163

1.66

1.70

1.0

5.89

13.17

u/ml

1.59

101

(3041806) Other cells [#/volume] in Blood by Manual count

195

1.59

1.68

1.5

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

101

1284

0.78

1.68

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

235

1.53

1.67

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.18

1.67

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

527

0.66

1.67

1.3

1.6

7.71

7.77

mmol/l

0.05

508

(3009677) Dengue virus Ab [Presence] in Serum

3.16

1.66

1.5

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

310

1.45

1.63

1.1

1.18

1.09

u/l

0.47

143

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.57

1.61

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.07

1.59

11.0

7.1

—

(40758292) HTLV I+II Ab panel - Serum

1.95

1.59

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.20

1.56

3.5

2.7

—

(3026470) Cobalt [Mass/volume] in Blood

280

1.47

1.56

1.9

2.0

2.89

3.65

ug/l

0.45

255

(3025577) Chromium [Mass/volume] in Blood

272

1.47

1.55

1.8

2.1

2.03

2.51

ug/l

0.60

229

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

330

1.43

1.55

1.7

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

261

2265

1.16

1.53

1.6

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

250

1.48

1.49

1.2

1.1

1696.14

1485.39

miu/ml

0.46

250

(3036048) Francisella tularensis Ab [Titer] in Serum

116

1.73

1.48

1.1

—

228.57

—

(3016750) Collection duration of Urine

251

1.48

1.47

2.9

2.1

500.23

493.70

min

0.14

186

(3043238) Trisomy 21 risk [Likelihood] in Fetus

179

1514

1.19

1.45

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.37

1.45

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

370

1.38

1.42

3.9

2.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

320

1.41

2.0

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

337

1.40

1.41

1.1

1.05

ratio

0.05

113

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.85

1.39

2.1

1.6

169.93

106.31

ng/l

0.43

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

181

1.55

1.39

1.0

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.77

1.38

1.2

1.5

27.55

26.30

g/l

0.09

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

137

1643

0.83

1.38

1.5

—

(3006462) Nitrate [Presence] in Urine

247

1.46

1.37

4.8

3.4

—

(40763590) HLA-DQ beta [Type]

2.94

1.36

1.0

—

(40760409) HLA-A [Type] by High resolution

2.94

1.36

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.94

1.36

1.0

—

(40760410) HLA-B [Type] by High resolution

2.94

1.36

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

1.67

1.33

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

342

1.38

1.31

1.1

—

(3013862) HLA-DP [Type]

2.78

1.28

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.89

1.28

1.1

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

2.08

1.27

1.2

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.94

1.27

1.7

1.4

33.14

544.02

u/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.27

1.0

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.29

1.26

1.0

1.1

—

4.99

u/l

—

(40768793) Breast Pathology biopsy report

155

1314

1.18

1.26

1.3

—

(4212803) Bone marrow aspirate examination

2.00

1.23

1.3

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

100

1.70

1.23

1.1

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.04

1.21

1.2

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

124

1.61

1.20

1.2

1.4

30.29

35.46

0.31

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

158

1349

1.18

1.20

1.5

150.96

154.47

pmol/l

0.03

152

1315

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

197

1.47

1.19

1.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.31

1.18

1.0

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

109

1.65

1.18

1.0

1.1

0.41

2.91

u/ml

0.55

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.50

1.15

1.4

556.10

536.78

nmol/l

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

343

1.34

1.14

7.0

6.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.69

1.13

1.0

1.1

—

(3019174) dRVVT (LA screen)

1.96

1.11

1.2

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.38

1.09

1.0

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.38

1.09

17.6

10.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

277

1.37

1.09

1.2

1.4

166.28

191.04

pmol/l

0.27

277

(3002619) Bacteria identified in Specimen by Culture

104

1.64

1.09

1.3

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

466

0.73

1.06

1.6

1.5

—

(3001556) Androgen free Index in Serum or Plasma

1.83

1.02

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.89

1.01

1.0

1.1

1.55

1.68

umol/24h

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.97

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

173

1.45

0.97

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.89

0.94

1.0

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.89

0.94

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.89

0.94

1.4

1.8

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

116

0.52

0.94

1.3

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

107

909

1.18

0.92

1.8

1.7

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.14

0.91

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

102

1.57

0.90

1.7

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

4426

43698

1.05

0.89

31.5

15.7

15.50

14.92

4.23

4370

42912

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.07

0.89

1.5

1.6

290.50

311.14

umol/24h

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

229

1.36

0.86

2.1

28.00

144.51

ug/min

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.94

0.84

1.0

1.3

0.20

1.57

u/ml

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.78

0.84

1.1

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.78

0.84

5.0

2.8

1.25

0.67

u/field

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

320

1.28

0.80

1.8

1.4

98.12

80.42

umol/l

0.40

320

(3004775) Volume in Urine collected for unspecified duration

338

1.27

0.80

2.9

2.3

744.62

611.98

1.17

221

(3000330) Specific gravity of Urine by Test strip

265

2419

1.10

0.79

5.3

3.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.82

0.79

1.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.77

0.0

1.1

—

8.36

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

252

1.31

0.76

1.0

1.1

91.19

90.91

0.02

190

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

132

1.44

0.75

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.70

0.75

1.4

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.64

0.75

1.5

1.6

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

125

1.44

0.72

1.7

3.0

99.63

124.53

ng/l

—

(40758358) Immune stain study

1.85

0.68

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.53

0.68

1.1

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

196

1786

1.10

0.65

1.8

1.9

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.59

0.61

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.46

0.61

1.5

2.2

8.50

7.45

mmol/l

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.58

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

273

1.25

0.57

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

159

1.32

0.55

1.1

1.2

22.00

17.50

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.58

0.54

1.7

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.58

0.54

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.48

0.53

1.3

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

371

0.81

0.52

1.8

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.50

0.51

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

608

6333

0.96

0.50

2.9

3.0

0.77

0.76

ug/l

0.04

444

4173

(3036670) Protein [Mass/volume] in Synovial fluid

127

1.34

0.49

1.4

1.2

35.17

38.72

g/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

905

8760

1.04

0.49

4.5

4.2

20.97

21.73

0.79

426

4204

(1617658) Protocol used for examination of sentinel lymph nodes

421

0.83

0.48

1.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

569

1.14

0.47

1.1

1.2

—

(3024263) Appearance of Synovial fluid

247

1.22

0.44

1.9

1.5

—

(3022475) Manganese [Moles/volume] in Blood

1.61

0.43

1.0

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.43

0.42

1.1

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.43

0.42

1.1

1.2

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

1.52

0.41

3.8

1.3

2.60

1.48

nmol/l

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.41

0.0

1.4

—

1.36

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.39

0.38

1.0

2.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

161

1.24

0.37

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

284

2984

0.95

0.37

1.8

1.7

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.40

0.35

1.5

1.1

5.17

17.40

u/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1054

0.92

0.34

6.9

3.4

30.60

25.92

mg/l

0.53

642

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.30

0.31

1.3

1.0

—

(3022621) pH of Urine by Test strip

346

3325

1.04

0.31

4.4

2.9

—

(3020650) Glucose [Presence] in Urine

138

1.23

0.30

1.2

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

356

3428

1.04

0.30

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.23

0.27

1.1

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

794

1.07

0.23

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

380

0.89

0.23

1.2

1.4

24.03

32.18

nmol/l

1.78

339

(3010937) Rubella virus Ab [Presence] in Serum

1.25

0.22

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

172

1.16

0.22

3.0

3.1

—

(3035933) Granulocytes/100 leukocytes in Blood

163

1.17

0.21

1.2

1.3

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

35.51

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

230

0.87

0.21

1.4

1.3

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

13.39

—

(3003338) MCHC [Mass/volume]

4282

42991

0.99

0.19

35.6

16.9

331.06

332.10

g/l

10.82

4253

42673

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

242

1.12

0.18

1.1

—

(3014891) Appearance of Pleural fluid

1.19

0.18

1.4

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.11

0.17

1.3

1.5

92.93

123.67

ug/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

215

2090

1.03

0.15

1.5

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.08

0.14

3.4

3.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.08

0.14

1.4

1.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.08

0.14

6.9

6.2

—

(3022689) Creatine [Moles/volume] in Urine

141

1.14

0.13

2.2

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

425

1.06

0.11

2.7

3.0

53.38

46.32

mg/l

0.09

317

(3051101) Glucose [Moles/volume] in Cord blood

0.80

0.07

8.5

6.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

284

1.06

0.07

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.05

0.07

1.3

2.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

314

0.96

0.05

1.0

312.83

332.60

ng/l

0.24

209

(4094501) Cardiovascular stress test using bicycle ergometer

121

1230

0.98

0.05

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

317

0.98

0.01

1.0

42.84

44.90

ng/l

0.12

206

(3014051) Protein [Presence] in Urine by Test strip

136

1364

1.00

0.00

3.6

2.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

315

0.98

0.00

1.0

881.75

714.24

ng/l

0.95

202

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

300

1.00

0.00

1.3

1.49

1.58

g/l

1.02

300

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

37.17

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

-0.00

0.0

1.3

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.00

-0.00

1.0

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1356.25

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.96

-0.00

1.8

1.6

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

7.07

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.89

-0.00

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_CANDIDIASIS and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_CANDIDIASIS	2.209 [1.96, 2.49]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.243

During the follow-up period (1.1.1998 — 31.12.2019), 3272 out of 18717 females with AB1_CANDIDIASIS died.

Males

Parameter	HR [95% CI]	p-value
AB1_CANDIDIASIS	2.783 [2.44, 3.17]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.028

During the follow-up period (1.1.1998 — 31.12.2019), 2863 out of 9856 males with AB1_CANDIDIASIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_CANDIDIASIS.

N-year risk	Females	Males
1	0.173%	0.462%
5	1.476%	3.097%
10	3.09%	8.088%
15	6.23%	15.566%
20	11.174%	25.078%

Relationships between endpoints

↥

Index endpoint: AB1_CANDIDIASIS – Candidiasis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Candidiasis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints